Gene Symbol | Gene ID | Gene Info |
---|---|---|
TCF7
|
ENSG00000081059.15 | transcription factor 7 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr5_133466786_133466937 | TCF7 | 7552 | 0.215650 | 0.93 | 2.2e-04 | Click! |
chr5_133466279_133466430 | TCF7 | 7045 | 0.218447 | 0.93 | 3.1e-04 | Click! |
chr5_133426970_133427238 | TCF7 | 23298 | 0.197990 | 0.92 | 3.9e-04 | Click! |
chr5_133439913_133440131 | TCF7 | 10380 | 0.225028 | 0.91 | 6.0e-04 | Click! |
chr5_133422379_133422553 | TCF7 | 27936 | 0.186621 | 0.91 | 7.4e-04 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr5_156675575_156675837 | 1.57 |
ENSG00000222086 |
. |
13397 |
0.13 |
chr14_98642580_98643004 | 1.29 |
ENSG00000222066 |
. |
155295 |
0.04 |
chr1_186258649_186258839 | 1.26 |
PRG4 |
proteoglycan 4 |
6661 |
0.2 |
chr2_101260921_101261203 | 1.25 |
ENSG00000265839 |
. |
43734 |
0.14 |
chr4_122110306_122110568 | 1.16 |
ENSG00000252183 |
. |
3621 |
0.28 |
chr4_109038555_109038892 | 0.98 |
LEF1 |
lymphoid enhancer-binding factor 1 |
48734 |
0.14 |
chr14_98689187_98689819 | 0.97 |
ENSG00000222066 |
. |
108584 |
0.07 |
chr12_9191656_9191852 | 0.94 |
A2M-AS1 |
A2M antisense RNA 1 |
26019 |
0.14 |
chr7_50434135_50434485 | 0.93 |
IKZF1 |
IKAROS family zinc finger 1 (Ikaros) |
67065 |
0.11 |
chr20_37503149_37503501 | 0.92 |
ENSG00000240474 |
. |
1912 |
0.35 |
chr22_22121909_22122114 | 0.91 |
ENSG00000200985 |
. |
24712 |
0.12 |
chr3_32344273_32344503 | 0.90 |
ENSG00000207857 |
. |
43168 |
0.14 |
chr5_39180395_39180675 | 0.89 |
FYB |
FYN binding protein |
22594 |
0.24 |
chr5_80400951_80401102 | 0.88 |
CTD-2193P3.2 |
|
9645 |
0.28 |
chr6_14636111_14636367 | 0.88 |
ENSG00000206960 |
. |
10527 |
0.32 |
chr16_85823495_85823646 | 0.88 |
RP11-568J23.6 |
|
2451 |
0.17 |
chr2_112946803_112946954 | 0.86 |
FBLN7 |
fibulin 7 |
7418 |
0.24 |
chr6_137710963_137711301 | 0.85 |
OLIG3 |
oligodendrocyte transcription factor 3 |
104399 |
0.07 |
chr3_66353500_66353733 | 0.84 |
ENSG00000206759 |
. |
9972 |
0.23 |
chr1_25970325_25970699 | 0.84 |
RP1-187B23.1 |
|
15090 |
0.18 |
chr1_100911854_100912179 | 0.84 |
RP5-837M10.4 |
|
39537 |
0.15 |
chrX_70219538_70219689 | 0.83 |
ENSG00000212605 |
. |
20675 |
0.16 |
chr5_75768199_75768431 | 0.82 |
IQGAP2 |
IQ motif containing GTPase activating protein 2 |
68066 |
0.12 |
chr6_41409902_41410353 | 0.82 |
ENSG00000238867 |
. |
86940 |
0.06 |
chr13_109062811_109063048 | 0.81 |
ENSG00000223177 |
. |
109250 |
0.07 |
chr5_55276808_55277096 | 0.80 |
IL6ST |
interleukin 6 signal transducer (gp130, oncostatin M receptor) |
1676 |
0.31 |
chr21_34557928_34558079 | 0.80 |
C21orf54 |
chromosome 21 open reading frame 54 |
15462 |
0.15 |
chr12_4926448_4926851 | 0.79 |
KCNA6 |
potassium voltage-gated channel, shaker-related subfamily, member 6 |
8307 |
0.2 |
chr11_45855868_45856049 | 0.79 |
CRY2 |
cryptochrome 2 (photolyase-like) |
12711 |
0.15 |
chr1_112145850_112146165 | 0.79 |
RAP1A |
RAP1A, member of RAS oncogene family |
16392 |
0.16 |
chr7_143899062_143899275 | 0.79 |
RP4-545C24.1 |
|
5615 |
0.12 |
chr2_109580892_109581113 | 0.79 |
EDAR |
ectodysplasin A receptor |
24723 |
0.24 |
chr3_51707561_51707749 | 0.76 |
TEX264 |
testis expressed 264 |
1744 |
0.3 |
chr10_17465687_17466122 | 0.76 |
ST8SIA6-AS1 |
ST8SIA6 antisense RNA 1 |
15878 |
0.18 |
chr21_32503893_32504052 | 0.76 |
TIAM1 |
T-cell lymphoma invasion and metastasis 1 |
1433 |
0.55 |
chr17_47828102_47828408 | 0.76 |
FAM117A |
family with sequence similarity 117, member A |
13238 |
0.15 |
chr9_20300810_20301049 | 0.76 |
ENSG00000221744 |
. |
5927 |
0.28 |
chr6_130454910_130455146 | 0.75 |
RP11-73O6.3 |
|
4313 |
0.28 |
chr21_44253024_44253531 | 0.75 |
WDR4 |
WD repeat domain 4 |
46364 |
0.13 |
chr5_39163244_39163586 | 0.75 |
FYB |
FYN binding protein |
39714 |
0.18 |
chr17_46514333_46514598 | 0.75 |
SKAP1 |
src kinase associated phosphoprotein 1 |
6884 |
0.15 |
chr1_236447358_236447555 | 0.74 |
ERO1LB |
ERO1-like beta (S. cerevisiae) |
2137 |
0.29 |
chr4_109029927_109030290 | 0.74 |
LEF1 |
lymphoid enhancer-binding factor 1 |
57349 |
0.12 |
chr12_65054552_65054703 | 0.74 |
RP11-338E21.3 |
|
5828 |
0.15 |
chr12_9920597_9920748 | 0.74 |
CD69 |
CD69 molecule |
7175 |
0.17 |
chr8_22395773_22395982 | 0.73 |
RP11-582J16.4 |
|
7041 |
0.12 |
chr14_22995523_22996056 | 0.73 |
TRAJ15 |
T cell receptor alpha joining 15 |
2791 |
0.16 |
chr4_6181726_6181911 | 0.73 |
JAKMIP1 |
janus kinase and microtubule interacting protein 1 |
14526 |
0.27 |
chr2_235332957_235333108 | 0.73 |
ARL4C |
ADP-ribosylation factor-like 4C |
72212 |
0.13 |
chr20_3794059_3794376 | 0.73 |
AP5S1 |
adaptor-related protein complex 5, sigma 1 subunit |
6961 |
0.12 |
chr2_28836401_28836726 | 0.72 |
PLB1 |
phospholipase B1 |
11777 |
0.21 |
chr17_16201694_16201963 | 0.72 |
ENSG00000221355 |
. |
16500 |
0.16 |
chr3_107697956_107698544 | 0.72 |
CD47 |
CD47 molecule |
78958 |
0.11 |
chr9_22064951_22065102 | 0.71 |
CDKN2B-AS1 |
CDKN2B antisense RNA 1 |
18276 |
0.2 |
chr1_62246804_62246985 | 0.71 |
ENSG00000200575 |
. |
35197 |
0.16 |
chr2_136348271_136348596 | 0.71 |
R3HDM1 |
R3H domain containing 1 |
4426 |
0.26 |
chr8_133990678_133991177 | 0.71 |
TG |
thyroglobulin |
14075 |
0.25 |
chr19_10254387_10254800 | 0.71 |
EIF3G |
eukaryotic translation initiation factor 3, subunit G |
24015 |
0.07 |
chr19_50834588_50834739 | 0.71 |
NR1H2 |
nuclear receptor subfamily 1, group H, member 2 |
1714 |
0.19 |
chr9_75073795_75073946 | 0.71 |
TMC1 |
transmembrane channel-like 1 |
62847 |
0.12 |
chr6_33663677_33663879 | 0.70 |
SBP1 |
SBP1; Uncharacterized protein |
304 |
0.84 |
chr2_202085430_202085650 | 0.70 |
CASP8 |
caspase 8, apoptosis-related cysteine peptidase |
12626 |
0.17 |
chr7_150361388_150361673 | 0.70 |
GIMAP2 |
GTPase, IMAP family member 2 |
21258 |
0.15 |
chr7_144045634_144046113 | 0.70 |
OR2A1-AS1 |
OR2A1 antisense RNA 1 |
5479 |
0.14 |
chr13_100193349_100193645 | 0.70 |
ENSG00000212197 |
. |
4847 |
0.21 |
chr12_55362221_55362689 | 0.70 |
TESPA1 |
thymocyte expressed, positive selection associated 1 |
4883 |
0.26 |
chr1_65341937_65342174 | 0.69 |
JAK1 |
Janus kinase 1 |
90132 |
0.08 |
chr22_21279965_21280312 | 0.69 |
CRKL |
v-crk avian sarcoma virus CT10 oncogene homolog-like |
8424 |
0.11 |
chr10_73839065_73839273 | 0.69 |
SPOCK2 |
sparc/osteonectin, cwcv and kazal-like domains proteoglycan (testican) 2 |
8917 |
0.24 |
chr17_5292178_5292426 | 0.69 |
RABEP1 |
rabaptin, RAB GTPase binding effector protein 1 |
11796 |
0.12 |
chr14_98482221_98482372 | 0.69 |
C14orf64 |
chromosome 14 open reading frame 64 |
37835 |
0.23 |
chr10_6555656_6555821 | 0.69 |
PRKCQ |
protein kinase C, theta |
66463 |
0.14 |
chr1_168482288_168482558 | 0.68 |
XCL2 |
chemokine (C motif) ligand 2 |
30812 |
0.2 |
chr13_99969194_99969489 | 0.68 |
GPR183 |
G protein-coupled receptor 183 |
9682 |
0.2 |
chr2_136809392_136809630 | 0.68 |
AC093391.2 |
|
39476 |
0.17 |
chr15_44957094_44957265 | 0.68 |
SPG11 |
spastic paraplegia 11 (autosomal recessive) |
1303 |
0.37 |
chr6_130543838_130543989 | 0.68 |
SAMD3 |
sterile alpha motif domain containing 3 |
45 |
0.99 |
chr1_76760906_76761057 | 0.68 |
ST6GALNAC3 |
ST6 (alpha-N-acetyl-neuraminyl-2,3-beta-galactosyl-1,3)-N-acetylgalactosaminide alpha-2,6-sialyltransferase 3 |
220577 |
0.02 |
chr17_53146305_53146456 | 0.68 |
STXBP4 |
syntaxin binding protein 4 |
69203 |
0.12 |
chr3_18445696_18446011 | 0.67 |
RP11-158G18.1 |
|
5274 |
0.25 |
chr2_202130226_202130626 | 0.67 |
CASP8 |
caspase 8, apoptosis-related cysteine peptidase |
3747 |
0.24 |
chr1_206958131_206958676 | 0.67 |
IL10 |
interleukin 10 |
12564 |
0.15 |
chr5_67553006_67553225 | 0.67 |
PIK3R1 |
phosphoinositide-3-kinase, regulatory subunit 1 (alpha) |
17389 |
0.26 |
chr6_28416917_28417068 | 0.66 |
ZSCAN23 |
zinc finger and SCAN domain containing 23 |
5748 |
0.18 |
chr16_68308627_68308943 | 0.66 |
SLC7A6 |
solute carrier family 7 (amino acid transporter light chain, y+L system), member 6 |
1903 |
0.15 |
chr5_14708043_14708418 | 0.66 |
FAM105B |
family with sequence similarity 105, member B |
26571 |
0.18 |
chr11_73724919_73725168 | 0.66 |
UCP3 |
uncoupling protein 3 (mitochondrial, proton carrier) |
4563 |
0.18 |
chr14_65237977_65238128 | 0.66 |
SPTB |
spectrin, beta, erythrocytic |
11216 |
0.2 |
chr7_100814110_100814261 | 0.66 |
VGF |
VGF nerve growth factor inducible |
5311 |
0.1 |
chr3_113952140_113952397 | 0.66 |
ZNF80 |
zinc finger protein 80 |
4157 |
0.2 |
chr7_3108313_3108464 | 0.65 |
CARD11 |
caspase recruitment domain family, member 11 |
24809 |
0.21 |
chr16_30392632_30392982 | 0.65 |
SEPT1 |
septin 1 |
945 |
0.31 |
chr14_22982375_22982791 | 0.65 |
TRAJ15 |
T cell receptor alpha joining 15 |
15997 |
0.1 |
chr3_3232879_3233052 | 0.65 |
CRBN |
cereblon |
11571 |
0.21 |
chr3_114026715_114026867 | 0.65 |
ENSG00000207770 |
. |
8625 |
0.18 |
chr17_1776866_1777017 | 0.65 |
RPA1 |
replication protein A1, 70kDa |
5388 |
0.17 |
chr1_53105846_53106022 | 0.65 |
FAM159A |
family with sequence similarity 159, member A |
6918 |
0.18 |
chr5_75633693_75633924 | 0.65 |
RP11-466P24.6 |
|
26521 |
0.23 |
chr13_52527464_52527703 | 0.65 |
ATP7B |
ATPase, Cu++ transporting, beta polypeptide |
8468 |
0.22 |
chr9_123665604_123665920 | 0.65 |
TRAF1 |
TNF receptor-associated factor 1 |
11088 |
0.19 |
chr2_131137316_131137652 | 0.65 |
PTPN18 |
protein tyrosine phosphatase, non-receptor type 18 (brain-derived) |
9822 |
0.15 |
chr1_227949174_227949396 | 0.65 |
SNAP47 |
synaptosomal-associated protein, 47kDa |
13521 |
0.16 |
chr6_2857051_2857287 | 0.65 |
ENSG00000266750 |
. |
2828 |
0.25 |
chr5_75627862_75628101 | 0.65 |
RP11-466P24.6 |
|
20694 |
0.25 |
chr7_27879709_27879984 | 0.65 |
TAX1BP1 |
Tax1 (human T-cell leukemia virus type I) binding protein 1 |
12426 |
0.23 |
chr22_31704289_31704785 | 0.64 |
ENSG00000212542 |
. |
3147 |
0.15 |
chr18_68325544_68325796 | 0.64 |
GTSCR1 |
Gilles de la Tourette syndrome chromosome region, candidate 1 |
7690 |
0.32 |
chr7_139320348_139320601 | 0.64 |
HIPK2 |
homeodomain interacting protein kinase 2 |
101367 |
0.07 |
chr3_128835970_128836121 | 0.64 |
RAB43 |
RAB43, member RAS oncogene family |
4579 |
0.14 |
chr3_107694284_107694711 | 0.64 |
CD47 |
CD47 molecule |
82711 |
0.11 |
chr2_61554743_61554914 | 0.64 |
USP34 |
ubiquitin specific peptidase 34 |
47360 |
0.15 |
chr6_2037823_2037974 | 0.64 |
GMDS |
GDP-mannose 4,6-dehydratase |
138327 |
0.05 |
chr20_47333015_47333275 | 0.64 |
ENSG00000251876 |
. |
22840 |
0.26 |
chr1_221900174_221900330 | 0.64 |
DUSP10 |
dual specificity phosphatase 10 |
10550 |
0.31 |
chr19_41809719_41809870 | 0.64 |
CCDC97 |
coiled-coil domain containing 97 |
6300 |
0.12 |
chr12_21766078_21766229 | 0.64 |
GYS2 |
glycogen synthase 2 (liver) |
8372 |
0.2 |
chr1_111176210_111176587 | 0.64 |
KCNA2 |
potassium voltage-gated channel, shaker-related subfamily, member 2 |
2302 |
0.29 |
chr16_89796408_89796559 | 0.64 |
ZNF276 |
zinc finger protein 276 |
8531 |
0.1 |
chr6_119211246_119211538 | 0.63 |
ASF1A |
anti-silencing function 1A histone chaperone |
3992 |
0.26 |
chrX_109233817_109234346 | 0.63 |
TMEM164 |
transmembrane protein 164 |
11782 |
0.26 |
chr6_128179962_128180113 | 0.63 |
THEMIS |
thymocyte selection associated |
42066 |
0.2 |
chr3_113954316_113954590 | 0.63 |
ZNF80 |
zinc finger protein 80 |
1972 |
0.3 |
chr6_90942853_90943078 | 0.63 |
BACH2 |
BTB and CNC homology 1, basic leucine zipper transcription factor 2 |
63496 |
0.13 |
chr2_231456751_231456978 | 0.63 |
ENSG00000199791 |
. |
5028 |
0.22 |
chr3_108553144_108553369 | 0.63 |
TRAT1 |
T cell receptor associated transmembrane adaptor 1 |
11637 |
0.26 |
chr2_149281634_149282124 | 0.63 |
MBD5 |
methyl-CpG binding domain protein 5 |
55585 |
0.16 |
chr12_69019853_69020073 | 0.63 |
ENSG00000206650 |
. |
1192 |
0.51 |
chr14_23000021_23000410 | 0.62 |
TRAJ15 |
T cell receptor alpha joining 15 |
1635 |
0.24 |
chr5_75625266_75625417 | 0.62 |
RP11-466P24.6 |
|
18054 |
0.26 |
chr1_226928650_226928860 | 0.62 |
ITPKB |
inositol-trisphosphate 3-kinase B |
1731 |
0.43 |
chr21_26944075_26944266 | 0.62 |
ENSG00000234883 |
. |
2122 |
0.31 |
chr2_169032889_169033150 | 0.62 |
STK39 |
serine threonine kinase 39 |
71632 |
0.13 |
chr9_135363022_135363199 | 0.62 |
ENSG00000252521 |
. |
66082 |
0.1 |
chr2_11898719_11898908 | 0.62 |
ENSG00000265056 |
. |
8757 |
0.14 |
chr16_79313853_79314004 | 0.62 |
ENSG00000222244 |
. |
15577 |
0.29 |
chr2_191936002_191936213 | 0.62 |
ENSG00000231858 |
. |
49855 |
0.11 |
chr17_38760715_38760866 | 0.62 |
SMARCE1 |
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily e, member 1 |
27752 |
0.12 |
chr7_144526418_144526569 | 0.61 |
TPK1 |
thiamin pyrophosphokinase 1 |
6653 |
0.26 |
chr21_40581899_40582053 | 0.61 |
BRWD1-IT1 |
BRWD1 intronic transcript 1 (non-protein coding) |
9755 |
0.16 |
chr1_24853977_24854306 | 0.61 |
ENSG00000266551 |
. |
2063 |
0.28 |
chr1_204461567_204461972 | 0.61 |
PIK3C2B |
phosphatidylinositol-4-phosphate 3-kinase, catalytic subunit type 2 beta |
2060 |
0.31 |
chrY_7156051_7156274 | 0.61 |
PRKY |
protein kinase, Y-linked, pseudogene |
13808 |
0.21 |
chr10_130855671_130855903 | 0.61 |
MGMT |
O-6-methylguanine-DNA methyltransferase |
409661 |
0.01 |
chr2_158287576_158287811 | 0.61 |
CYTIP |
cytohesin 1 interacting protein |
8233 |
0.23 |
chr13_41150205_41150813 | 0.61 |
AL133318.1 |
Uncharacterized protein |
39186 |
0.18 |
chr10_73844841_73844992 | 0.61 |
SPOCK2 |
sparc/osteonectin, cwcv and kazal-like domains proteoglycan (testican) 2 |
3170 |
0.3 |
chr17_47814021_47814341 | 0.61 |
FAM117A |
family with sequence similarity 117, member A |
12292 |
0.14 |
chr1_154411097_154411248 | 0.61 |
IL6R |
interleukin 6 receptor |
4043 |
0.16 |
chr15_38987308_38987526 | 0.60 |
C15orf53 |
chromosome 15 open reading frame 53 |
1382 |
0.57 |
chr2_162869916_162870102 | 0.60 |
AC008063.2 |
|
59757 |
0.12 |
chr13_74826745_74826896 | 0.60 |
ENSG00000206617 |
. |
36531 |
0.22 |
chr2_12268194_12268483 | 0.60 |
ENSG00000264089 |
. |
70918 |
0.12 |
chr13_41188423_41188902 | 0.60 |
FOXO1 |
forkhead box O1 |
52072 |
0.14 |
chr3_189052350_189052584 | 0.60 |
TPRG1-AS2 |
TPRG1 antisense RNA 2 |
94084 |
0.09 |
chr14_98485289_98485572 | 0.60 |
C14orf64 |
chromosome 14 open reading frame 64 |
40969 |
0.22 |
chr6_13686993_13687323 | 0.60 |
RANBP9 |
RAN binding protein 9 |
22 |
0.98 |
chr13_40782938_40783221 | 0.60 |
ENSG00000207458 |
. |
17885 |
0.29 |
chr9_100861250_100861401 | 0.59 |
TRIM14 |
tripartite motif containing 14 |
6482 |
0.2 |
chr14_91822252_91822567 | 0.59 |
ENSG00000265856 |
. |
22352 |
0.2 |
chr2_44901800_44902050 | 0.59 |
ENSG00000252896 |
. |
107344 |
0.07 |
chr14_98664260_98664734 | 0.59 |
ENSG00000222066 |
. |
133590 |
0.05 |
chr6_137548884_137549136 | 0.59 |
IFNGR1 |
interferon gamma receptor 1 |
8424 |
0.27 |
chr11_35353117_35353423 | 0.59 |
SLC1A2 |
solute carrier family 1 (glial high affinity glutamate transporter), member 2 |
30195 |
0.17 |
chr1_151869347_151869629 | 0.59 |
THEM4 |
thioesterase superfamily member 4 |
12625 |
0.12 |
chr1_100908166_100908711 | 0.59 |
RP5-837M10.4 |
|
43115 |
0.14 |
chr9_140357412_140357637 | 0.59 |
NSMF |
NMDA receptor synaptonuclear signaling and neuronal migration factor |
3738 |
0.15 |
chrX_153401077_153401228 | 0.59 |
OPN1LW |
opsin 1 (cone pigments), long-wave-sensitive |
8546 |
0.13 |
chr21_44833868_44834074 | 0.59 |
SIK1 |
salt-inducible kinase 1 |
13037 |
0.28 |
chr9_15121686_15121837 | 0.59 |
ENSG00000251960 |
. |
21526 |
0.24 |
chr3_73014643_73014836 | 0.59 |
GXYLT2 |
glucoside xylosyltransferase 2 |
10373 |
0.2 |
chr2_97607152_97607303 | 0.59 |
ENSG00000252845 |
. |
15325 |
0.15 |
chr11_95407407_95407558 | 0.59 |
FAM76B |
family with sequence similarity 76, member B |
112487 |
0.06 |
chr19_35697571_35697754 | 0.59 |
FAM187B |
family with sequence similarity 187, member B |
21970 |
0.09 |
chr14_100559814_100559997 | 0.59 |
EVL |
Enah/Vasp-like |
3379 |
0.18 |
chr12_55372614_55372982 | 0.59 |
TESPA1 |
thymocyte expressed, positive selection associated 1 |
2824 |
0.31 |
chr13_30952584_30952735 | 0.59 |
KATNAL1 |
katanin p60 subunit A-like 1 |
71038 |
0.11 |
chr11_34270944_34271235 | 0.58 |
ENSG00000201867 |
. |
60368 |
0.13 |
chr6_154477451_154478235 | 0.58 |
OPRM1 |
opioid receptor, mu 1 |
70201 |
0.13 |
chr1_101587217_101587368 | 0.58 |
ENSG00000252765 |
. |
11417 |
0.2 |
chr1_204549341_204549569 | 0.58 |
ENSG00000200408 |
. |
17806 |
0.14 |
chr3_186757183_186757348 | 0.58 |
ST6GAL1 |
ST6 beta-galactosamide alpha-2,6-sialyltranferase 1 |
4266 |
0.28 |
chr7_86840512_86840739 | 0.58 |
ENSG00000200397 |
. |
7403 |
0.18 |
chr4_6182509_6182660 | 0.58 |
JAKMIP1 |
janus kinase and microtubule interacting protein 1 |
13760 |
0.27 |
chr2_198713166_198713570 | 0.58 |
PLCL1 |
phospholipase C-like 1 |
38386 |
0.18 |
chr16_27417389_27417582 | 0.58 |
IL21R |
interleukin 21 receptor |
3062 |
0.27 |
chr2_204607032_204607284 | 0.58 |
ENSG00000211573 |
. |
22363 |
0.19 |
chr1_183858331_183858737 | 0.58 |
COLGALT2 |
collagen beta(1-O)galactosyltransferase 2 |
57218 |
0.14 |
chrX_135669720_135670141 | 0.58 |
ENSG00000252320 |
. |
4531 |
0.17 |
chr2_70666868_70667067 | 0.58 |
ENSG00000215996 |
. |
15789 |
0.15 |
chr1_1951998_1952149 | 0.58 |
GABRD |
gamma-aminobutyric acid (GABA) A receptor, delta |
1293 |
0.33 |
chr10_7554785_7554936 | 0.58 |
RP11-385N23.1 |
|
20309 |
0.21 |
chr1_233060073_233060303 | 0.58 |
NTPCR |
nucleoside-triphosphatase, cancer-related |
26182 |
0.23 |
chr10_73491368_73491519 | 0.58 |
C10orf105 |
chromosome 10 open reading frame 105 |
6138 |
0.23 |
chr3_188551858_188552009 | 0.58 |
TPRG1 |
tumor protein p63 regulated 1 |
113070 |
0.07 |
chr9_100866822_100867164 | 0.57 |
TRIM14 |
tripartite motif containing 14 |
12150 |
0.18 |
chr17_63429770_63429921 | 0.57 |
ENSG00000265189 |
. |
13067 |
0.29 |
chr14_89065832_89066179 | 0.57 |
ZC3H14 |
zinc finger CCCH-type containing 14 |
5224 |
0.2 |
chr6_90984611_90985132 | 0.57 |
BACH2 |
BTB and CNC homology 1, basic leucine zipper transcription factor 2 |
21590 |
0.23 |
chr7_142045030_142045181 | 0.57 |
PRSS3P3 |
protease, serine, 3 pseudogene 3 |
55496 |
0.14 |
chr22_40316109_40316336 | 0.57 |
GRAP2 |
GRB2-related adaptor protein 2 |
6373 |
0.19 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.9 | 0.9 | GO:0002326 | B cell lineage commitment(GO:0002326) |
0.7 | 2.9 | GO:0033152 | immunoglobulin V(D)J recombination(GO:0033152) |
0.7 | 2.9 | GO:0030854 | positive regulation of granulocyte differentiation(GO:0030854) |
0.5 | 0.5 | GO:0002513 | tolerance induction to self antigen(GO:0002513) |
0.5 | 3.4 | GO:0045066 | regulatory T cell differentiation(GO:0045066) |
0.5 | 1.9 | GO:0001911 | negative regulation of leukocyte mediated cytotoxicity(GO:0001911) |
0.4 | 1.3 | GO:0002249 | lymphocyte anergy(GO:0002249) T cell tolerance induction(GO:0002517) regulation of T cell tolerance induction(GO:0002664) positive regulation of T cell tolerance induction(GO:0002666) regulation of T cell anergy(GO:0002667) positive regulation of T cell anergy(GO:0002669) T cell anergy(GO:0002870) regulation of lymphocyte anergy(GO:0002911) positive regulation of lymphocyte anergy(GO:0002913) |
0.4 | 1.2 | GO:0050862 | positive regulation of T cell receptor signaling pathway(GO:0050862) |
0.4 | 1.2 | GO:0010040 | response to iron(II) ion(GO:0010040) |
0.4 | 0.4 | GO:0032693 | negative regulation of interleukin-10 production(GO:0032693) |
0.4 | 0.7 | GO:0031580 | membrane raft polarization(GO:0001766) membrane raft distribution(GO:0031580) |
0.4 | 0.7 | GO:0046642 | negative regulation of alpha-beta T cell proliferation(GO:0046642) |
0.3 | 2.4 | GO:0007172 | signal complex assembly(GO:0007172) |
0.3 | 3.3 | GO:0043368 | positive T cell selection(GO:0043368) |
0.3 | 2.6 | GO:0002839 | regulation of response to tumor cell(GO:0002834) positive regulation of response to tumor cell(GO:0002836) regulation of immune response to tumor cell(GO:0002837) positive regulation of immune response to tumor cell(GO:0002839) |
0.3 | 0.6 | GO:0010661 | positive regulation of muscle cell apoptotic process(GO:0010661) positive regulation of smooth muscle cell apoptotic process(GO:0034393) |
0.3 | 0.9 | GO:0048388 | endosomal lumen acidification(GO:0048388) |
0.3 | 0.9 | GO:0010957 | negative regulation of calcidiol 1-monooxygenase activity(GO:0010956) negative regulation of vitamin D biosynthetic process(GO:0010957) negative regulation of vitamin metabolic process(GO:0046137) |
0.3 | 1.2 | GO:0032237 | activation of store-operated calcium channel activity(GO:0032237) regulation of store-operated calcium channel activity(GO:1901339) positive regulation of store-operated calcium channel activity(GO:1901341) |
0.3 | 0.9 | GO:0035405 | histone-threonine phosphorylation(GO:0035405) |
0.3 | 0.9 | GO:0045722 | positive regulation of gluconeogenesis(GO:0045722) |
0.3 | 0.6 | GO:0006154 | adenosine catabolic process(GO:0006154) |
0.3 | 1.4 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
0.3 | 2.6 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
0.3 | 1.4 | GO:0007256 | activation of JNKK activity(GO:0007256) |
0.3 | 0.6 | GO:0002713 | negative regulation of B cell mediated immunity(GO:0002713) negative regulation of immunoglobulin mediated immune response(GO:0002890) |
0.3 | 2.3 | GO:0006491 | N-glycan processing(GO:0006491) |
0.3 | 1.1 | GO:0002335 | mature B cell differentiation(GO:0002335) |
0.3 | 0.8 | GO:0006772 | thiamine metabolic process(GO:0006772) |
0.3 | 0.8 | GO:0034219 | carbohydrate transmembrane transport(GO:0034219) |
0.3 | 1.3 | GO:0070120 | ciliary neurotrophic factor-mediated signaling pathway(GO:0070120) |
0.3 | 1.8 | GO:0048013 | ephrin receptor signaling pathway(GO:0048013) |
0.3 | 1.3 | GO:0043518 | negative regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043518) negative regulation of signal transduction by p53 class mediator(GO:1901797) |
0.3 | 0.5 | GO:0032071 | regulation of endodeoxyribonuclease activity(GO:0032071) |
0.2 | 1.2 | GO:0070670 | response to interleukin-4(GO:0070670) |
0.2 | 1.0 | GO:0002691 | regulation of cellular extravasation(GO:0002691) |
0.2 | 0.2 | GO:0045074 | interleukin-10 biosynthetic process(GO:0042091) regulation of interleukin-10 biosynthetic process(GO:0045074) |
0.2 | 0.5 | GO:0030223 | neutrophil differentiation(GO:0030223) |
0.2 | 0.7 | GO:0010511 | regulation of phosphatidylinositol biosynthetic process(GO:0010511) |
0.2 | 16.2 | GO:0050852 | T cell receptor signaling pathway(GO:0050852) |
0.2 | 0.9 | GO:0032776 | DNA methylation on cytosine(GO:0032776) C-5 methylation of cytosine(GO:0090116) |
0.2 | 0.2 | GO:0061154 | endothelial tube morphogenesis(GO:0061154) |
0.2 | 0.2 | GO:0010831 | positive regulation of myotube differentiation(GO:0010831) |
0.2 | 0.2 | GO:0002523 | leukocyte migration involved in inflammatory response(GO:0002523) |
0.2 | 0.6 | GO:0018076 | N-terminal peptidyl-lysine acetylation(GO:0018076) |
0.2 | 0.6 | GO:0006167 | AMP biosynthetic process(GO:0006167) |
0.2 | 0.4 | GO:0060916 | mesenchymal cell proliferation involved in lung development(GO:0060916) |
0.2 | 0.6 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
0.2 | 1.0 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
0.2 | 0.4 | GO:0002418 | immune response to tumor cell(GO:0002418) |
0.2 | 0.6 | GO:0031936 | negative regulation of chromatin silencing(GO:0031936) |
0.2 | 0.4 | GO:0048537 | mucosal-associated lymphoid tissue development(GO:0048537) |
0.2 | 0.9 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
0.2 | 0.7 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
0.2 | 0.7 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
0.2 | 0.5 | GO:0070777 | D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
0.2 | 0.9 | GO:0007195 | adenylate cyclase-inhibiting dopamine receptor signaling pathway(GO:0007195) |
0.2 | 0.9 | GO:0002483 | antigen processing and presentation of endogenous peptide antigen(GO:0002483) antigen processing and presentation of endogenous peptide antigen via MHC class I(GO:0019885) |
0.2 | 0.7 | GO:0030910 | olfactory placode formation(GO:0030910) olfactory placode development(GO:0071698) olfactory placode morphogenesis(GO:0071699) |
0.2 | 0.5 | GO:0036037 | CD8-positive, alpha-beta T cell activation(GO:0036037) CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
0.2 | 0.3 | GO:0002726 | positive regulation of T cell cytokine production(GO:0002726) |
0.2 | 0.3 | GO:0002677 | negative regulation of chronic inflammatory response(GO:0002677) |
0.2 | 0.2 | GO:0032641 | lymphotoxin A production(GO:0032641) lymphotoxin A biosynthetic process(GO:0042109) |
0.2 | 0.2 | GO:0061298 | retina vasculature development in camera-type eye(GO:0061298) retina vasculature morphogenesis in camera-type eye(GO:0061299) |
0.2 | 0.3 | GO:0015801 | aromatic amino acid transport(GO:0015801) |
0.2 | 2.3 | GO:0046834 | lipid phosphorylation(GO:0046834) |
0.2 | 0.3 | GO:0010592 | positive regulation of lamellipodium assembly(GO:0010592) positive regulation of lamellipodium organization(GO:1902745) |
0.2 | 0.3 | GO:0002707 | negative regulation of lymphocyte mediated immunity(GO:0002707) negative regulation of T cell mediated immunity(GO:0002710) |
0.2 | 0.5 | GO:0002507 | tolerance induction(GO:0002507) |
0.2 | 0.3 | GO:0032415 | regulation of sodium:proton antiporter activity(GO:0032415) regulation of sodium ion transmembrane transport(GO:1902305) regulation of sodium ion transmembrane transporter activity(GO:2000649) |
0.2 | 1.4 | GO:0000381 | regulation of alternative mRNA splicing, via spliceosome(GO:0000381) |
0.2 | 0.6 | GO:0008054 | negative regulation of cyclin-dependent protein serine/threonine kinase by cyclin degradation(GO:0008054) |
0.2 | 0.3 | GO:0048304 | positive regulation of isotype switching to IgG isotypes(GO:0048304) |
0.2 | 0.8 | GO:0045898 | regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045898) |
0.2 | 0.3 | GO:0050686 | negative regulation of mRNA processing(GO:0050686) negative regulation of mRNA metabolic process(GO:1903312) |
0.1 | 1.8 | GO:0000303 | response to superoxide(GO:0000303) |
0.1 | 0.6 | GO:0022614 | membrane to membrane docking(GO:0022614) |
0.1 | 0.6 | GO:0017182 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
0.1 | 0.4 | GO:0072600 | protein targeting to Golgi(GO:0000042) establishment of protein localization to Golgi(GO:0072600) |
0.1 | 0.4 | GO:0031061 | negative regulation of histone methylation(GO:0031061) |
0.1 | 0.4 | GO:0035025 | positive regulation of Rho protein signal transduction(GO:0035025) |
0.1 | 0.3 | GO:0050765 | negative regulation of phagocytosis(GO:0050765) |
0.1 | 0.4 | GO:0015820 | branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
0.1 | 0.4 | GO:0045056 | transcytosis(GO:0045056) |
0.1 | 0.4 | GO:0030505 | inorganic diphosphate transport(GO:0030505) |
0.1 | 0.4 | GO:0010761 | fibroblast migration(GO:0010761) |
0.1 | 0.4 | GO:0016242 | negative regulation of macroautophagy(GO:0016242) |
0.1 | 0.4 | GO:0032695 | negative regulation of interleukin-12 production(GO:0032695) |
0.1 | 0.4 | GO:0045341 | MHC class I biosynthetic process(GO:0045341) regulation of MHC class I biosynthetic process(GO:0045343) |
0.1 | 0.7 | GO:0002717 | positive regulation of natural killer cell mediated immunity(GO:0002717) positive regulation of natural killer cell mediated cytotoxicity(GO:0045954) |
0.1 | 0.3 | GO:0046666 | retinal cell programmed cell death(GO:0046666) regulation of retinal cell programmed cell death(GO:0046668) |
0.1 | 0.4 | GO:0042996 | regulation of Golgi to plasma membrane protein transport(GO:0042996) |
0.1 | 0.3 | GO:0050955 | thermoception(GO:0050955) |
0.1 | 0.4 | GO:0006089 | lactate metabolic process(GO:0006089) |
0.1 | 0.7 | GO:0090205 | positive regulation of cholesterol metabolic process(GO:0090205) |
0.1 | 0.1 | GO:0046951 | acetoacetic acid biosynthetic process(GO:0043441) cellular ketone body metabolic process(GO:0046950) ketone body biosynthetic process(GO:0046951) |
0.1 | 0.3 | GO:0033962 | cytoplasmic mRNA processing body assembly(GO:0033962) |
0.1 | 0.1 | GO:0002820 | negative regulation of adaptive immune response(GO:0002820) negative regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains(GO:0002823) |
0.1 | 0.4 | GO:2000758 | positive regulation of histone acetylation(GO:0035066) positive regulation of protein acetylation(GO:1901985) positive regulation of peptidyl-lysine acetylation(GO:2000758) |
0.1 | 1.3 | GO:0019059 | obsolete initiation of viral infection(GO:0019059) |
0.1 | 0.1 | GO:0022417 | protein maturation by protein folding(GO:0022417) |
0.1 | 0.1 | GO:1900120 | regulation of receptor binding(GO:1900120) negative regulation of receptor binding(GO:1900121) |
0.1 | 0.4 | GO:0030812 | negative regulation of nucleotide catabolic process(GO:0030812) |
0.1 | 0.4 | GO:0045292 | mRNA cis splicing, via spliceosome(GO:0045292) |
0.1 | 0.8 | GO:0048617 | embryonic foregut morphogenesis(GO:0048617) |
0.1 | 0.6 | GO:0060017 | parathyroid gland development(GO:0060017) |
0.1 | 0.1 | GO:0032966 | negative regulation of collagen biosynthetic process(GO:0032966) |
0.1 | 0.5 | GO:0021604 | cranial nerve structural organization(GO:0021604) facial nerve morphogenesis(GO:0021610) facial nerve structural organization(GO:0021612) |
0.1 | 0.1 | GO:0045683 | negative regulation of epidermal cell differentiation(GO:0045605) negative regulation of epidermis development(GO:0045683) |
0.1 | 0.4 | GO:0006642 | triglyceride mobilization(GO:0006642) |
0.1 | 0.5 | GO:0032097 | positive regulation of response to food(GO:0032097) positive regulation of appetite(GO:0032100) |
0.1 | 0.1 | GO:0051088 | PMA-inducible membrane protein ectodomain proteolysis(GO:0051088) |
0.1 | 3.5 | GO:0031294 | lymphocyte costimulation(GO:0031294) T cell costimulation(GO:0031295) |
0.1 | 0.2 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
0.1 | 0.4 | GO:0046548 | retinal rod cell development(GO:0046548) |
0.1 | 0.2 | GO:0009143 | nucleoside triphosphate catabolic process(GO:0009143) |
0.1 | 0.4 | GO:0072161 | mesenchymal cell differentiation involved in kidney development(GO:0072161) metanephric mesenchymal cell differentiation(GO:0072162) mesenchymal cell differentiation involved in renal system development(GO:2001012) |
0.1 | 0.5 | GO:0034086 | maintenance of sister chromatid cohesion(GO:0034086) maintenance of mitotic sister chromatid cohesion(GO:0034088) |
0.1 | 0.2 | GO:0033622 | integrin activation(GO:0033622) |
0.1 | 0.5 | GO:0015919 | peroxisomal membrane transport(GO:0015919) |
0.1 | 0.5 | GO:0006689 | ganglioside catabolic process(GO:0006689) |
0.1 | 0.1 | GO:0046007 | negative regulation of activated T cell proliferation(GO:0046007) |
0.1 | 0.2 | GO:0045354 | interferon-alpha biosynthetic process(GO:0045349) regulation of interferon-alpha biosynthetic process(GO:0045354) positive regulation of interferon-alpha biosynthetic process(GO:0045356) |
0.1 | 0.2 | GO:0060586 | multicellular organismal iron ion homeostasis(GO:0060586) |
0.1 | 0.4 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
0.1 | 0.6 | GO:0000380 | alternative mRNA splicing, via spliceosome(GO:0000380) |
0.1 | 0.4 | GO:0034391 | smooth muscle cell apoptotic process(GO:0034390) regulation of smooth muscle cell apoptotic process(GO:0034391) negative regulation of smooth muscle cell apoptotic process(GO:0034392) |
0.1 | 0.3 | GO:0033083 | regulation of immature T cell proliferation(GO:0033083) regulation of immature T cell proliferation in thymus(GO:0033084) negative regulation of immature T cell proliferation(GO:0033087) negative regulation of immature T cell proliferation in thymus(GO:0033088) |
0.1 | 1.1 | GO:0031648 | protein destabilization(GO:0031648) |
0.1 | 0.1 | GO:0032621 | interleukin-18 production(GO:0032621) regulation of interleukin-18 production(GO:0032661) |
0.1 | 0.2 | GO:0001821 | histamine secretion(GO:0001821) |
0.1 | 0.7 | GO:0016553 | base conversion or substitution editing(GO:0016553) |
0.1 | 0.3 | GO:0002085 | inhibition of neuroepithelial cell differentiation(GO:0002085) |
0.1 | 0.4 | GO:0001840 | neural plate morphogenesis(GO:0001839) neural plate development(GO:0001840) |
0.1 | 0.7 | GO:0060456 | positive regulation of digestive system process(GO:0060456) |
0.1 | 0.6 | GO:0031498 | nucleosome disassembly(GO:0006337) chromatin disassembly(GO:0031498) protein-DNA complex disassembly(GO:0032986) |
0.1 | 1.1 | GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
0.1 | 0.3 | GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
0.1 | 0.8 | GO:0006198 | cAMP catabolic process(GO:0006198) |
0.1 | 1.0 | GO:0032456 | endocytic recycling(GO:0032456) |
0.1 | 1.2 | GO:0043508 | negative regulation of JUN kinase activity(GO:0043508) |
0.1 | 0.3 | GO:0009048 | dosage compensation by inactivation of X chromosome(GO:0009048) |
0.1 | 0.2 | GO:1901419 | regulation of response to alcohol(GO:1901419) |
0.1 | 0.2 | GO:0019731 | antimicrobial humoral response(GO:0019730) antibacterial humoral response(GO:0019731) |
0.1 | 1.8 | GO:0043124 | negative regulation of I-kappaB kinase/NF-kappaB signaling(GO:0043124) |
0.1 | 0.3 | GO:0015917 | aminophospholipid transport(GO:0015917) |
0.1 | 0.3 | GO:0061099 | negative regulation of protein tyrosine kinase activity(GO:0061099) |
0.1 | 0.3 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
0.1 | 0.4 | GO:0000183 | chromatin silencing at rDNA(GO:0000183) |
0.1 | 0.4 | GO:0003056 | regulation of vascular smooth muscle contraction(GO:0003056) |
0.1 | 0.5 | GO:0042535 | positive regulation of tumor necrosis factor biosynthetic process(GO:0042535) |
0.1 | 1.5 | GO:0016601 | Rac protein signal transduction(GO:0016601) |
0.1 | 0.1 | GO:0007144 | female meiosis I(GO:0007144) |
0.1 | 0.3 | GO:0051182 | coenzyme transport(GO:0051182) |
0.1 | 0.3 | GO:0009138 | pyrimidine nucleoside diphosphate metabolic process(GO:0009138) |
0.1 | 0.5 | GO:0006020 | inositol metabolic process(GO:0006020) |
0.1 | 1.4 | GO:0060334 | regulation of response to interferon-gamma(GO:0060330) regulation of interferon-gamma-mediated signaling pathway(GO:0060334) |
0.1 | 0.2 | GO:0010159 | specification of organ position(GO:0010159) |
0.1 | 0.1 | GO:0042492 | gamma-delta T cell differentiation(GO:0042492) |
0.1 | 0.1 | GO:0051712 | positive regulation of killing of cells of other organism(GO:0051712) |
0.1 | 0.3 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.1 | 0.3 | GO:0072698 | protein localization to cytoskeleton(GO:0044380) protein localization to microtubule cytoskeleton(GO:0072698) |
0.1 | 0.4 | GO:0032747 | interleukin-23 production(GO:0032627) regulation of interleukin-23 production(GO:0032667) positive regulation of interleukin-23 production(GO:0032747) |
0.1 | 0.1 | GO:0035162 | embryonic hemopoiesis(GO:0035162) |
0.1 | 0.4 | GO:0050732 | negative regulation of peptidyl-tyrosine phosphorylation(GO:0050732) |
0.1 | 0.4 | GO:0060023 | soft palate development(GO:0060023) |
0.1 | 0.3 | GO:0042339 | keratan sulfate metabolic process(GO:0042339) |
0.1 | 0.1 | GO:0048302 | regulation of isotype switching to IgG isotypes(GO:0048302) |
0.1 | 0.5 | GO:0051208 | sequestering of calcium ion(GO:0051208) |
0.1 | 0.4 | GO:0010508 | positive regulation of autophagy(GO:0010508) |
0.1 | 0.3 | GO:0035520 | monoubiquitinated protein deubiquitination(GO:0035520) |
0.1 | 0.2 | GO:0030252 | growth hormone secretion(GO:0030252) |
0.1 | 0.3 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
0.1 | 0.2 | GO:0034695 | response to prostaglandin E(GO:0034695) |
0.1 | 0.4 | GO:0006104 | succinyl-CoA metabolic process(GO:0006104) |
0.1 | 0.4 | GO:0000085 | mitotic G2 phase(GO:0000085) G2 phase(GO:0051319) |
0.1 | 0.4 | GO:0002921 | negative regulation of humoral immune response(GO:0002921) |
0.1 | 0.5 | GO:0043267 | negative regulation of potassium ion transport(GO:0043267) |
0.1 | 0.4 | GO:0032814 | regulation of natural killer cell activation(GO:0032814) |
0.1 | 0.2 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
0.1 | 0.1 | GO:0032494 | response to peptidoglycan(GO:0032494) |
0.1 | 0.5 | GO:0003310 | pancreatic A cell differentiation(GO:0003310) |
0.1 | 0.1 | GO:0010536 | regulation of activation of Janus kinase activity(GO:0010533) regulation of activation of JAK2 kinase activity(GO:0010534) positive regulation of activation of JAK2 kinase activity(GO:0010535) positive regulation of activation of Janus kinase activity(GO:0010536) |
0.1 | 0.3 | GO:0032968 | positive regulation of transcription elongation from RNA polymerase II promoter(GO:0032968) |
0.1 | 0.4 | GO:0045040 | outer mitochondrial membrane organization(GO:0007008) protein import into mitochondrial outer membrane(GO:0045040) |
0.1 | 0.2 | GO:0016556 | mRNA modification(GO:0016556) |
0.1 | 0.3 | GO:0060049 | regulation of protein glycosylation(GO:0060049) |
0.1 | 0.6 | GO:0007035 | vacuolar acidification(GO:0007035) |
0.1 | 0.5 | GO:1902115 | regulation of organelle assembly(GO:1902115) |
0.1 | 0.4 | GO:0006975 | DNA damage induced protein phosphorylation(GO:0006975) |
0.1 | 0.4 | GO:0060770 | negative regulation of epithelial cell proliferation involved in prostate gland development(GO:0060770) |
0.1 | 0.5 | GO:0009103 | lipopolysaccharide biosynthetic process(GO:0009103) |
0.1 | 0.3 | GO:0045672 | positive regulation of osteoclast differentiation(GO:0045672) |
0.1 | 0.3 | GO:0002323 | natural killer cell activation involved in immune response(GO:0002323) natural killer cell degranulation(GO:0043320) |
0.1 | 0.1 | GO:0032410 | negative regulation of transporter activity(GO:0032410) |
0.1 | 1.0 | GO:0050853 | B cell receptor signaling pathway(GO:0050853) |
0.1 | 0.3 | GO:0046006 | regulation of activated T cell proliferation(GO:0046006) |
0.1 | 0.7 | GO:0015671 | oxygen transport(GO:0015671) |
0.1 | 0.3 | GO:0002430 | complement receptor mediated signaling pathway(GO:0002430) |
0.1 | 0.3 | GO:0006562 | proline catabolic process(GO:0006562) |
0.1 | 0.4 | GO:0010614 | negative regulation of cardiac muscle hypertrophy(GO:0010614) |
0.1 | 1.1 | GO:0042776 | mitochondrial ATP synthesis coupled proton transport(GO:0042776) |
0.1 | 0.9 | GO:0021516 | dorsal spinal cord development(GO:0021516) |
0.1 | 0.3 | GO:0045875 | negative regulation of sister chromatid cohesion(GO:0045875) |
0.1 | 0.2 | GO:0010216 | maintenance of DNA methylation(GO:0010216) |
0.1 | 0.3 | GO:0006498 | N-terminal protein lipidation(GO:0006498) |
0.1 | 0.5 | GO:0051294 | establishment of mitotic spindle orientation(GO:0000132) establishment of spindle orientation(GO:0051294) |
0.1 | 0.3 | GO:0031529 | ruffle organization(GO:0031529) |
0.1 | 0.2 | GO:0050687 | negative regulation of defense response to virus(GO:0050687) |
0.1 | 0.2 | GO:0009215 | purine deoxyribonucleoside triphosphate metabolic process(GO:0009215) |
0.1 | 0.1 | GO:0002019 | regulation of renal output by angiotensin(GO:0002019) |
0.1 | 0.4 | GO:0043628 | ncRNA 3'-end processing(GO:0043628) |
0.1 | 0.3 | GO:0034063 | stress granule assembly(GO:0034063) |
0.1 | 2.3 | GO:0050772 | positive regulation of axonogenesis(GO:0050772) |
0.1 | 0.2 | GO:0055075 | potassium ion homeostasis(GO:0055075) |
0.1 | 0.7 | GO:0006983 | ER overload response(GO:0006983) |
0.1 | 0.2 | GO:0007100 | mitotic centrosome separation(GO:0007100) |
0.1 | 0.1 | GO:0021797 | forebrain anterior/posterior pattern specification(GO:0021797) lens induction in camera-type eye(GO:0060235) |
0.1 | 0.4 | GO:0010758 | regulation of macrophage chemotaxis(GO:0010758) |
0.1 | 0.2 | GO:0060856 | establishment of blood-brain barrier(GO:0060856) |
0.1 | 0.3 | GO:0000098 | sulfur amino acid catabolic process(GO:0000098) |
0.1 | 2.3 | GO:1901185 | negative regulation of epidermal growth factor receptor signaling pathway(GO:0042059) negative regulation of ERBB signaling pathway(GO:1901185) |
0.1 | 0.2 | GO:0070897 | RNA polymerase II transcriptional preinitiation complex assembly(GO:0051123) DNA-templated transcriptional preinitiation complex assembly(GO:0070897) |
0.1 | 0.1 | GO:0032653 | regulation of interleukin-10 production(GO:0032653) |
0.1 | 0.1 | GO:0035883 | type B pancreatic cell differentiation(GO:0003309) enteroendocrine cell differentiation(GO:0035883) |
0.1 | 0.2 | GO:0017085 | response to insecticide(GO:0017085) |
0.1 | 0.2 | GO:0000733 | DNA strand renaturation(GO:0000733) |
0.1 | 0.6 | GO:0045948 | positive regulation of translational initiation(GO:0045948) |
0.1 | 1.0 | GO:0046676 | negative regulation of insulin secretion(GO:0046676) |
0.1 | 0.4 | GO:0033631 | cell-cell adhesion mediated by integrin(GO:0033631) |
0.1 | 0.3 | GO:0006999 | nuclear pore organization(GO:0006999) |
0.1 | 0.1 | GO:1900078 | positive regulation of insulin receptor signaling pathway(GO:0046628) positive regulation of cellular response to insulin stimulus(GO:1900078) |
0.1 | 0.3 | GO:0046479 | glycosphingolipid catabolic process(GO:0046479) |
0.1 | 0.2 | GO:0045603 | positive regulation of endothelial cell differentiation(GO:0045603) |
0.1 | 0.2 | GO:0042149 | cellular response to glucose starvation(GO:0042149) |
0.1 | 0.5 | GO:0006308 | DNA catabolic process(GO:0006308) |
0.1 | 0.4 | GO:0060123 | regulation of growth hormone secretion(GO:0060123) |
0.1 | 0.2 | GO:0001774 | microglial cell activation(GO:0001774) microglial cell activation involved in immune response(GO:0002282) |
0.1 | 0.3 | GO:0000012 | single strand break repair(GO:0000012) |
0.1 | 0.2 | GO:0071542 | dopaminergic neuron differentiation(GO:0071542) |
0.1 | 0.3 | GO:0006422 | aspartyl-tRNA aminoacylation(GO:0006422) |
0.1 | 0.4 | GO:0034260 | negative regulation of GTPase activity(GO:0034260) |
0.1 | 0.2 | GO:2000114 | regulation of establishment of cell polarity(GO:2000114) |
0.1 | 0.3 | GO:0033522 | histone H2A ubiquitination(GO:0033522) |
0.1 | 0.2 | GO:0060766 | negative regulation of androgen receptor signaling pathway(GO:0060766) |
0.1 | 0.1 | GO:0010980 | regulation of vitamin D 24-hydroxylase activity(GO:0010979) positive regulation of vitamin D 24-hydroxylase activity(GO:0010980) |
0.1 | 0.1 | GO:0003148 | outflow tract septum morphogenesis(GO:0003148) |
0.1 | 0.2 | GO:0040016 | embryonic cleavage(GO:0040016) |
0.1 | 1.4 | GO:0006997 | nucleus organization(GO:0006997) |
0.1 | 0.4 | GO:0060765 | regulation of androgen receptor signaling pathway(GO:0060765) |
0.1 | 0.2 | GO:0060972 | left/right pattern formation(GO:0060972) |
0.1 | 0.2 | GO:0045910 | negative regulation of DNA recombination(GO:0045910) |
0.1 | 0.3 | GO:0051657 | maintenance of organelle location(GO:0051657) |
0.1 | 0.2 | GO:0017014 | protein nitrosylation(GO:0017014) peptidyl-cysteine S-nitrosylation(GO:0018119) |
0.1 | 0.2 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
0.1 | 0.1 | GO:0048859 | formation of anatomical boundary(GO:0048859) |
0.1 | 0.1 | GO:0006290 | pyrimidine dimer repair(GO:0006290) |
0.1 | 0.3 | GO:0060710 | chorio-allantoic fusion(GO:0060710) |
0.1 | 0.1 | GO:0060836 | lymphatic endothelial cell differentiation(GO:0060836) |
0.1 | 0.1 | GO:0002448 | mast cell mediated immunity(GO:0002448) |
0.1 | 0.2 | GO:0002862 | negative regulation of inflammatory response to antigenic stimulus(GO:0002862) |
0.1 | 0.3 | GO:0046831 | regulation of RNA export from nucleus(GO:0046831) |
0.1 | 0.2 | GO:0032506 | cytokinetic process(GO:0032506) |
0.1 | 0.1 | GO:0032075 | positive regulation of nuclease activity(GO:0032075) |
0.1 | 0.3 | GO:0060080 | inhibitory postsynaptic potential(GO:0060080) |
0.1 | 0.1 | GO:0010642 | negative regulation of platelet-derived growth factor receptor signaling pathway(GO:0010642) |
0.1 | 0.4 | GO:0030903 | notochord development(GO:0030903) |
0.1 | 0.3 | GO:0032461 | positive regulation of protein oligomerization(GO:0032461) |
0.1 | 2.4 | GO:0060333 | interferon-gamma-mediated signaling pathway(GO:0060333) |
0.1 | 1.7 | GO:0000080 | mitotic G1 phase(GO:0000080) |
0.1 | 0.9 | GO:0043666 | regulation of phosphoprotein phosphatase activity(GO:0043666) |
0.1 | 0.2 | GO:0006855 | drug transmembrane transport(GO:0006855) |
0.1 | 0.1 | GO:0051775 | response to redox state(GO:0051775) |
0.1 | 0.1 | GO:0060669 | embryonic placenta morphogenesis(GO:0060669) labyrinthine layer morphogenesis(GO:0060713) |
0.1 | 0.1 | GO:0019042 | viral latency(GO:0019042) |
0.1 | 0.1 | GO:0042159 | lipoprotein catabolic process(GO:0042159) |
0.1 | 0.3 | GO:0019987 | obsolete negative regulation of anti-apoptosis(GO:0019987) |
0.1 | 0.2 | GO:0010919 | regulation of inositol phosphate biosynthetic process(GO:0010919) positive regulation of inositol phosphate biosynthetic process(GO:0060732) |
0.1 | 0.3 | GO:0030970 | retrograde protein transport, ER to cytosol(GO:0030970) |
0.1 | 0.2 | GO:0045990 | carbon catabolite regulation of transcription(GO:0045990) regulation of transcription by glucose(GO:0046015) |
0.1 | 0.3 | GO:0014010 | Schwann cell proliferation(GO:0014010) |
0.1 | 0.5 | GO:0071108 | protein K48-linked deubiquitination(GO:0071108) |
0.1 | 0.4 | GO:0043550 | regulation of lipid kinase activity(GO:0043550) |
0.1 | 0.1 | GO:0021869 | forebrain ventricular zone progenitor cell division(GO:0021869) |
0.1 | 0.1 | GO:0060179 | male mating behavior(GO:0060179) |
0.1 | 0.1 | GO:0016198 | axon choice point recognition(GO:0016198) axon midline choice point recognition(GO:0016199) |
0.1 | 0.4 | GO:0006538 | glutamate catabolic process(GO:0006538) |
0.1 | 0.1 | GO:0045759 | negative regulation of action potential(GO:0045759) |
0.1 | 0.1 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
0.1 | 0.4 | GO:0006658 | phosphatidylserine metabolic process(GO:0006658) |
0.1 | 0.3 | GO:0033169 | histone H3-K9 demethylation(GO:0033169) |
0.1 | 0.1 | GO:0072178 | nephric duct morphogenesis(GO:0072178) |
0.1 | 0.2 | GO:0030187 | melatonin metabolic process(GO:0030186) melatonin biosynthetic process(GO:0030187) |
0.1 | 0.1 | GO:0061030 | epithelial cell differentiation involved in mammary gland alveolus development(GO:0061030) |
0.1 | 0.3 | GO:0006474 | N-terminal protein amino acid acetylation(GO:0006474) |
0.1 | 0.3 | GO:0008214 | protein demethylation(GO:0006482) protein dealkylation(GO:0008214) |
0.1 | 0.1 | GO:0006591 | ornithine metabolic process(GO:0006591) |
0.1 | 0.4 | GO:0006379 | mRNA cleavage(GO:0006379) |
0.1 | 0.2 | GO:0060999 | positive regulation of dendritic spine development(GO:0060999) |
0.1 | 1.2 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
0.1 | 0.2 | GO:0006189 | 'de novo' IMP biosynthetic process(GO:0006189) |
0.1 | 0.3 | GO:2001234 | negative regulation of mitochondrion organization(GO:0010823) negative regulation of release of cytochrome c from mitochondria(GO:0090201) negative regulation of apoptotic signaling pathway(GO:2001234) |
0.1 | 0.1 | GO:0032692 | negative regulation of interleukin-1 production(GO:0032692) |
0.1 | 0.2 | GO:0035455 | response to interferon-alpha(GO:0035455) |
0.1 | 0.1 | GO:0043276 | anoikis(GO:0043276) |
0.1 | 0.3 | GO:0070493 | thrombin receptor signaling pathway(GO:0070493) |
0.1 | 0.3 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
0.1 | 0.1 | GO:0048714 | positive regulation of oligodendrocyte differentiation(GO:0048714) |
0.1 | 1.0 | GO:0032012 | regulation of ARF protein signal transduction(GO:0032012) |
0.1 | 0.1 | GO:0032914 | positive regulation of transforming growth factor beta1 production(GO:0032914) |
0.1 | 0.1 | GO:0033145 | positive regulation of intracellular steroid hormone receptor signaling pathway(GO:0033145) |
0.1 | 0.1 | GO:0060632 | regulation of microtubule-based movement(GO:0060632) |
0.1 | 0.2 | GO:0050670 | regulation of lymphocyte proliferation(GO:0050670) |
0.1 | 0.3 | GO:0060263 | regulation of respiratory burst(GO:0060263) |
0.1 | 0.5 | GO:0046348 | amino sugar catabolic process(GO:0046348) glucosamine-containing compound catabolic process(GO:1901072) |
0.1 | 0.2 | GO:0090084 | negative regulation of inclusion body assembly(GO:0090084) |
0.1 | 0.4 | GO:0035246 | peptidyl-arginine N-methylation(GO:0035246) |
0.1 | 0.4 | GO:0051496 | positive regulation of stress fiber assembly(GO:0051496) |
0.1 | 0.1 | GO:0032236 | obsolete positive regulation of calcium ion transport via store-operated calcium channel activity(GO:0032236) |
0.1 | 0.3 | GO:0021903 | rostrocaudal neural tube patterning(GO:0021903) |
0.1 | 0.2 | GO:0032418 | lysosome localization(GO:0032418) |
0.1 | 0.5 | GO:0008535 | respiratory chain complex IV assembly(GO:0008535) |
0.1 | 0.2 | GO:0042098 | T cell proliferation(GO:0042098) |
0.1 | 0.3 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
0.1 | 0.3 | GO:0060040 | retinal bipolar neuron differentiation(GO:0060040) |
0.1 | 0.1 | GO:0010866 | regulation of triglyceride biosynthetic process(GO:0010866) |
0.1 | 0.1 | GO:0001787 | natural killer cell proliferation(GO:0001787) |
0.1 | 0.2 | GO:0008298 | intracellular mRNA localization(GO:0008298) |
0.1 | 0.2 | GO:0031167 | rRNA methylation(GO:0031167) |
0.1 | 0.4 | GO:0032784 | regulation of DNA-templated transcription, elongation(GO:0032784) |
0.1 | 0.4 | GO:0006287 | base-excision repair, gap-filling(GO:0006287) |
0.1 | 0.2 | GO:0018094 | protein polyglycylation(GO:0018094) |
0.1 | 0.1 | GO:0002281 | macrophage activation involved in immune response(GO:0002281) |
0.1 | 0.1 | GO:0021754 | facial nucleus development(GO:0021754) |
0.1 | 0.9 | GO:0016578 | histone deubiquitination(GO:0016578) |
0.1 | 4.8 | GO:0018196 | peptidyl-asparagine modification(GO:0018196) protein N-linked glycosylation via asparagine(GO:0018279) |
0.1 | 0.1 | GO:0007638 | mechanosensory behavior(GO:0007638) |
0.1 | 0.1 | GO:0043568 | positive regulation of insulin-like growth factor receptor signaling pathway(GO:0043568) |
0.1 | 0.2 | GO:0031440 | regulation of mRNA 3'-end processing(GO:0031440) positive regulation of mRNA 3'-end processing(GO:0031442) positive regulation of mRNA processing(GO:0050685) positive regulation of mRNA metabolic process(GO:1903313) |
0.1 | 0.1 | GO:0042713 | sperm ejaculation(GO:0042713) |
0.1 | 0.2 | GO:0045793 | positive regulation of cell size(GO:0045793) |
0.1 | 0.4 | GO:0030101 | natural killer cell activation(GO:0030101) |
0.1 | 0.2 | GO:0071816 | protein insertion into ER membrane(GO:0045048) tail-anchored membrane protein insertion into ER membrane(GO:0071816) |
0.1 | 0.1 | GO:0045136 | development of secondary sexual characteristics(GO:0045136) |
0.1 | 0.4 | GO:0046580 | negative regulation of Ras protein signal transduction(GO:0046580) |
0.1 | 0.4 | GO:0051290 | protein heterotetramerization(GO:0051290) |
0.1 | 0.1 | GO:0060218 | hematopoietic stem cell differentiation(GO:0060218) |
0.1 | 0.5 | GO:0006465 | signal peptide processing(GO:0006465) |
0.1 | 0.6 | GO:0008625 | extrinsic apoptotic signaling pathway via death domain receptors(GO:0008625) extrinsic apoptotic signaling pathway(GO:0097191) |
0.1 | 0.4 | GO:1904031 | positive regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045737) positive regulation of cyclin-dependent protein kinase activity(GO:1904031) |
0.1 | 0.5 | GO:0033687 | osteoblast proliferation(GO:0033687) |
0.1 | 0.2 | GO:0000389 | mRNA 3'-splice site recognition(GO:0000389) |
0.1 | 0.2 | GO:0021542 | dentate gyrus development(GO:0021542) |
0.1 | 0.1 | GO:0051790 | short-chain fatty acid biosynthetic process(GO:0051790) |
0.1 | 0.3 | GO:0006376 | mRNA splice site selection(GO:0006376) |
0.1 | 0.2 | GO:0009804 | phenylpropanoid metabolic process(GO:0009698) coumarin metabolic process(GO:0009804) |
0.1 | 0.9 | GO:0000245 | spliceosomal complex assembly(GO:0000245) |
0.1 | 0.3 | GO:0006545 | glycine biosynthetic process(GO:0006545) |
0.1 | 0.2 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
0.1 | 0.1 | GO:0060992 | response to fungicide(GO:0060992) |
0.1 | 0.2 | GO:0051001 | negative regulation of nitric-oxide synthase activity(GO:0051001) |
0.1 | 0.1 | GO:0051665 | membrane raft localization(GO:0051665) |
0.1 | 0.2 | GO:0010901 | regulation of very-low-density lipoprotein particle remodeling(GO:0010901) |
0.1 | 0.2 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
0.1 | 0.2 | GO:0034626 | fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
0.1 | 1.0 | GO:0000718 | nucleotide-excision repair, DNA damage removal(GO:0000718) DNA excision(GO:0044349) |
0.1 | 0.1 | GO:0015825 | L-serine transport(GO:0015825) |
0.1 | 0.6 | GO:0071044 | histone mRNA catabolic process(GO:0071044) |
0.1 | 0.1 | GO:0032119 | sequestering of zinc ion(GO:0032119) |
0.1 | 0.1 | GO:0045071 | negative regulation of viral genome replication(GO:0045071) |
0.1 | 1.7 | GO:0031047 | gene silencing by RNA(GO:0031047) |
0.1 | 0.1 | GO:0048539 | bone marrow development(GO:0048539) |
0.1 | 0.1 | GO:0051014 | actin filament severing(GO:0051014) |
0.1 | 0.1 | GO:0071371 | response to follicle-stimulating hormone(GO:0032354) cellular response to gonadotropin stimulus(GO:0071371) |
0.1 | 0.2 | GO:0006930 | substrate-dependent cell migration, cell extension(GO:0006930) |
0.1 | 0.9 | GO:0043484 | regulation of RNA splicing(GO:0043484) |
0.1 | 0.2 | GO:0008053 | mitochondrial fusion(GO:0008053) |
0.1 | 0.1 | GO:0009405 | pathogenesis(GO:0009405) |
0.1 | 0.2 | GO:0045767 | obsolete regulation of anti-apoptosis(GO:0045767) |
0.1 | 0.2 | GO:0008608 | attachment of spindle microtubules to kinetochore(GO:0008608) |
0.1 | 0.2 | GO:0045618 | positive regulation of keratinocyte differentiation(GO:0045618) |
0.1 | 0.2 | GO:0007064 | mitotic sister chromatid cohesion(GO:0007064) |
0.1 | 0.4 | GO:0002286 | T cell activation involved in immune response(GO:0002286) |
0.1 | 1.3 | GO:0003333 | amino acid transmembrane transport(GO:0003333) |
0.1 | 0.2 | GO:0009301 | snRNA transcription(GO:0009301) |
0.1 | 0.2 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
0.1 | 0.6 | GO:0045576 | mast cell activation(GO:0045576) |
0.1 | 0.1 | GO:0043653 | mitochondrial fragmentation involved in apoptotic process(GO:0043653) |
0.1 | 0.5 | GO:0034112 | positive regulation of homotypic cell-cell adhesion(GO:0034112) |
0.1 | 0.3 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.1 | 0.1 | GO:0007262 | STAT protein import into nucleus(GO:0007262) |
0.1 | 0.1 | GO:2000279 | negative regulation of telomerase activity(GO:0051974) negative regulation of DNA biosynthetic process(GO:2000279) |
0.1 | 0.1 | GO:0033158 | regulation of protein import into nucleus, translocation(GO:0033158) |
0.1 | 0.1 | GO:0001569 | patterning of blood vessels(GO:0001569) |
0.1 | 0.1 | GO:0046185 | aldehyde catabolic process(GO:0046185) |
0.1 | 0.2 | GO:0051452 | intracellular pH reduction(GO:0051452) |
0.1 | 0.1 | GO:1903309 | negative regulation of chromatin modification(GO:1903309) |
0.1 | 0.1 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
0.1 | 1.0 | GO:0008633 | obsolete activation of pro-apoptotic gene products(GO:0008633) |
0.1 | 0.2 | GO:0048535 | lymph node development(GO:0048535) |
0.1 | 0.1 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
0.1 | 0.2 | GO:0060272 | embryonic skeletal joint morphogenesis(GO:0060272) embryonic skeletal joint development(GO:0072498) |
0.1 | 0.1 | GO:0048670 | regulation of collateral sprouting(GO:0048670) |
0.1 | 0.1 | GO:0008653 | lipopolysaccharide metabolic process(GO:0008653) |
0.1 | 0.1 | GO:0009313 | oligosaccharide catabolic process(GO:0009313) |
0.1 | 0.1 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
0.1 | 0.3 | GO:0015780 | nucleotide-sugar transport(GO:0015780) |
0.1 | 0.3 | GO:0070071 | proton-transporting two-sector ATPase complex assembly(GO:0070071) |
0.1 | 0.1 | GO:0034447 | very-low-density lipoprotein particle clearance(GO:0034447) |
0.0 | 0.1 | GO:0048478 | replication fork protection(GO:0048478) |
0.0 | 1.2 | GO:0016579 | protein deubiquitination(GO:0016579) |
0.0 | 0.2 | GO:0090399 | replicative senescence(GO:0090399) |
0.0 | 0.0 | GO:0022030 | cerebral cortex radial glia guided migration(GO:0021801) layer formation in cerebral cortex(GO:0021819) telencephalon glial cell migration(GO:0022030) |
0.0 | 0.0 | GO:0071391 | cellular response to estrogen stimulus(GO:0071391) |
0.0 | 0.1 | GO:0018343 | protein farnesylation(GO:0018343) |
0.0 | 0.2 | GO:0010389 | regulation of G2/M transition of mitotic cell cycle(GO:0010389) regulation of cell cycle G2/M phase transition(GO:1902749) |
0.0 | 0.0 | GO:0033085 | negative regulation of T cell differentiation in thymus(GO:0033085) negative regulation of thymocyte aggregation(GO:2000399) |
0.0 | 0.4 | GO:0007032 | endosome organization(GO:0007032) |
0.0 | 0.1 | GO:0032715 | negative regulation of interleukin-6 production(GO:0032715) |
0.0 | 0.1 | GO:0051103 | DNA ligation involved in DNA repair(GO:0051103) |
0.0 | 0.4 | GO:0072599 | protein targeting to ER(GO:0045047) establishment of protein localization to endoplasmic reticulum(GO:0072599) |
0.0 | 0.3 | GO:0098927 | early endosome to late endosome transport(GO:0045022) vesicle-mediated transport between endosomal compartments(GO:0098927) |
0.0 | 0.0 | GO:0016080 | synaptic vesicle targeting(GO:0016080) |
0.0 | 0.1 | GO:0032728 | positive regulation of interferon-beta production(GO:0032728) |
0.0 | 0.0 | GO:0048266 | behavioral response to pain(GO:0048266) |
0.0 | 0.5 | GO:0009311 | oligosaccharide metabolic process(GO:0009311) |
0.0 | 0.1 | GO:0010837 | regulation of keratinocyte proliferation(GO:0010837) |
0.0 | 0.1 | GO:0033483 | gas homeostasis(GO:0033483) |
0.0 | 0.1 | GO:0039656 | modulation by virus of host gene expression(GO:0039656) |
0.0 | 0.2 | GO:0051489 | regulation of filopodium assembly(GO:0051489) |
0.0 | 0.1 | GO:0051481 | negative regulation of cytosolic calcium ion concentration(GO:0051481) |
0.0 | 0.1 | GO:0009648 | photoperiodism(GO:0009648) |
0.0 | 0.1 | GO:0060088 | auditory receptor cell morphogenesis(GO:0002093) auditory receptor cell stereocilium organization(GO:0060088) |
0.0 | 0.1 | GO:0032811 | negative regulation of epinephrine secretion(GO:0032811) |
0.0 | 1.1 | GO:0006829 | zinc II ion transport(GO:0006829) |
0.0 | 0.1 | GO:0042789 | mRNA transcription from RNA polymerase II promoter(GO:0042789) regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0043619) |
0.0 | 0.0 | GO:0002925 | positive regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002925) |
0.0 | 0.1 | GO:0033314 | mitotic DNA replication checkpoint(GO:0033314) |
0.0 | 0.2 | GO:0051205 | protein insertion into membrane(GO:0051205) |
0.0 | 0.7 | GO:0034199 | activation of protein kinase A activity(GO:0034199) |
0.0 | 0.1 | GO:0032790 | ribosome disassembly(GO:0032790) |
0.0 | 0.0 | GO:1901970 | positive regulation of mitotic metaphase/anaphase transition(GO:0045842) positive regulation of mitotic sister chromatid separation(GO:1901970) positive regulation of metaphase/anaphase transition of cell cycle(GO:1902101) |
0.0 | 0.1 | GO:0002495 | antigen processing and presentation of peptide antigen via MHC class II(GO:0002495) |
0.0 | 1.1 | GO:0000186 | activation of MAPKK activity(GO:0000186) |
0.0 | 0.1 | GO:0071168 | protein localization to chromatin(GO:0071168) |
0.0 | 0.1 | GO:0070828 | heterochromatin assembly(GO:0031507) heterochromatin organization(GO:0070828) |
0.0 | 0.3 | GO:0046716 | muscle cell cellular homeostasis(GO:0046716) |
0.0 | 0.0 | GO:1900006 | positive regulation of dendrite development(GO:1900006) |
0.0 | 0.4 | GO:0042771 | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:0042771) |
0.0 | 0.0 | GO:0001833 | inner cell mass cell proliferation(GO:0001833) |
0.0 | 0.2 | GO:0051482 | positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway(GO:0051482) |
0.0 | 0.0 | GO:0019054 | modulation by virus of host process(GO:0019054) modulation by symbiont of host cellular process(GO:0044068) |
0.0 | 0.1 | GO:0032703 | negative regulation of interleukin-2 production(GO:0032703) |
0.0 | 0.7 | GO:0016574 | histone ubiquitination(GO:0016574) |
0.0 | 0.2 | GO:0043984 | histone H4-K16 acetylation(GO:0043984) |
0.0 | 0.0 | GO:0072367 | regulation of lipid transport by regulation of transcription from RNA polymerase II promoter(GO:0072367) |
0.0 | 0.1 | GO:0001706 | endoderm formation(GO:0001706) |
0.0 | 0.4 | GO:0016558 | protein import into peroxisome matrix(GO:0016558) |
0.0 | 1.0 | GO:0000289 | nuclear-transcribed mRNA poly(A) tail shortening(GO:0000289) |
0.0 | 0.1 | GO:0051567 | histone H3-K9 methylation(GO:0051567) histone H3-K9 modification(GO:0061647) |
0.0 | 0.2 | GO:1903556 | negative regulation of tumor necrosis factor production(GO:0032720) negative regulation of tumor necrosis factor superfamily cytokine production(GO:1903556) |
0.0 | 0.3 | GO:0006862 | nucleotide transport(GO:0006862) |
0.0 | 0.4 | GO:0048199 | vesicle targeting, to, from or within Golgi(GO:0048199) |
0.0 | 0.3 | GO:0043331 | response to dsRNA(GO:0043331) |
0.0 | 0.2 | GO:0032210 | regulation of telomere maintenance via telomerase(GO:0032210) |
0.0 | 0.5 | GO:0007257 | activation of JUN kinase activity(GO:0007257) |
0.0 | 0.1 | GO:2000171 | negative regulation of dendrite development(GO:2000171) |
0.0 | 0.1 | GO:0070857 | regulation of bile acid biosynthetic process(GO:0070857) regulation of bile acid metabolic process(GO:1904251) |
0.0 | 0.3 | GO:0001662 | behavioral fear response(GO:0001662) behavioral defense response(GO:0002209) |
0.0 | 0.0 | GO:0002360 | T cell lineage commitment(GO:0002360) |
0.0 | 0.1 | GO:0021615 | glossopharyngeal nerve development(GO:0021563) glossopharyngeal nerve morphogenesis(GO:0021615) |
0.0 | 1.5 | GO:0006968 | cellular defense response(GO:0006968) |
0.0 | 0.2 | GO:0035235 | ionotropic glutamate receptor signaling pathway(GO:0035235) |
0.0 | 0.3 | GO:0006903 | vesicle targeting(GO:0006903) |
0.0 | 0.3 | GO:0046339 | diacylglycerol metabolic process(GO:0046339) |
0.0 | 0.0 | GO:0034122 | negative regulation of toll-like receptor signaling pathway(GO:0034122) |
0.0 | 0.0 | GO:0044273 | sulfur compound catabolic process(GO:0044273) |
0.0 | 0.0 | GO:0071158 | positive regulation of cell cycle arrest(GO:0071158) |
0.0 | 0.1 | GO:0009120 | deoxyribonucleoside metabolic process(GO:0009120) |
0.0 | 0.1 | GO:0046618 | drug export(GO:0046618) |
0.0 | 0.3 | GO:0009253 | peptidoglycan metabolic process(GO:0000270) peptidoglycan catabolic process(GO:0009253) |
0.0 | 0.3 | GO:0007512 | adult heart development(GO:0007512) |
0.0 | 0.0 | GO:0042508 | tyrosine phosphorylation of Stat1 protein(GO:0042508) |
0.0 | 0.0 | GO:0000722 | telomere maintenance via recombination(GO:0000722) |
0.0 | 0.7 | GO:0021549 | cerebellum development(GO:0021549) |
0.0 | 0.2 | GO:0044065 | regulation of respiratory system process(GO:0044065) |
0.0 | 0.1 | GO:0021514 | ventral spinal cord interneuron differentiation(GO:0021514) ventral spinal cord interneuron specification(GO:0021521) regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification(GO:0021913) cell fate specification involved in pattern specification(GO:0060573) ventral spinal cord interneuron fate commitment(GO:0060579) cell fate commitment involved in pattern specification(GO:0060581) |
0.0 | 0.3 | GO:0051085 | chaperone mediated protein folding requiring cofactor(GO:0051085) |
0.0 | 0.0 | GO:0060510 | lung saccule development(GO:0060430) Type II pneumocyte differentiation(GO:0060510) |
0.0 | 0.2 | GO:0035082 | axoneme assembly(GO:0035082) |
0.0 | 0.2 | GO:0003084 | positive regulation of systemic arterial blood pressure(GO:0003084) |
0.0 | 0.1 | GO:0050691 | regulation of defense response to virus by host(GO:0050691) |
0.0 | 0.1 | GO:0032922 | circadian regulation of gene expression(GO:0032922) |
0.0 | 0.3 | GO:0001829 | trophectodermal cell differentiation(GO:0001829) |
0.0 | 2.1 | GO:0035023 | regulation of Rho protein signal transduction(GO:0035023) |
0.0 | 0.0 | GO:0006346 | methylation-dependent chromatin silencing(GO:0006346) |
0.0 | 0.1 | GO:0060527 | prostate glandular acinus morphogenesis(GO:0060526) prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis(GO:0060527) |
0.0 | 0.2 | GO:0000089 | mitotic metaphase(GO:0000089) |
0.0 | 0.0 | GO:0051608 | histamine transport(GO:0051608) |
0.0 | 0.2 | GO:0007128 | meiotic prophase I(GO:0007128) |
0.0 | 0.1 | GO:0009296 | obsolete flagellum assembly(GO:0009296) |
0.0 | 0.1 | GO:0015959 | diadenosine polyphosphate metabolic process(GO:0015959) |
0.0 | 0.1 | GO:0051451 | myoblast migration(GO:0051451) |
0.0 | 1.9 | GO:0006405 | RNA export from nucleus(GO:0006405) |
0.0 | 0.0 | GO:0032462 | regulation of protein homooligomerization(GO:0032462) |
0.0 | 0.1 | GO:0032808 | lacrimal gland development(GO:0032808) |
0.0 | 0.0 | GO:0000154 | rRNA modification(GO:0000154) |
0.0 | 0.4 | GO:0007379 | segment specification(GO:0007379) |
0.0 | 0.1 | GO:0050651 | dermatan sulfate proteoglycan biosynthetic process(GO:0050651) |
0.0 | 0.1 | GO:0050869 | negative regulation of B cell activation(GO:0050869) |
0.0 | 0.1 | GO:0070646 | protein modification by small protein removal(GO:0070646) |
0.0 | 0.1 | GO:0016572 | histone phosphorylation(GO:0016572) |
0.0 | 0.6 | GO:0071377 | cellular response to glucagon stimulus(GO:0071377) |
0.0 | 0.1 | GO:0042226 | interleukin-6 biosynthetic process(GO:0042226) |
0.0 | 0.1 | GO:0007130 | synaptonemal complex assembly(GO:0007130) |
0.0 | 0.4 | GO:0015800 | acidic amino acid transport(GO:0015800) L-glutamate transport(GO:0015813) |
0.0 | 0.1 | GO:0030263 | apoptotic chromosome condensation(GO:0030263) |
0.0 | 1.6 | GO:0007498 | mesoderm development(GO:0007498) |
0.0 | 0.2 | GO:0034434 | steroid esterification(GO:0034433) sterol esterification(GO:0034434) cholesterol esterification(GO:0034435) |
0.0 | 0.1 | GO:0060605 | tube lumen cavitation(GO:0060605) salivary gland cavitation(GO:0060662) |
0.0 | 0.2 | GO:0060603 | mammary gland duct morphogenesis(GO:0060603) |
0.0 | 1.8 | GO:0006338 | chromatin remodeling(GO:0006338) |
0.0 | 0.2 | GO:0072273 | metanephric nephron morphogenesis(GO:0072273) |
0.0 | 0.2 | GO:0006013 | mannose metabolic process(GO:0006013) |
0.0 | 0.1 | GO:0045351 | type I interferon biosynthetic process(GO:0045351) |
0.0 | 0.3 | GO:0016226 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
0.0 | 0.1 | GO:0060712 | spongiotrophoblast layer development(GO:0060712) |
0.0 | 0.2 | GO:0046149 | porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
0.0 | 0.1 | GO:0033600 | negative regulation of mammary gland epithelial cell proliferation(GO:0033600) |
0.0 | 1.6 | GO:0008360 | regulation of cell shape(GO:0008360) |
0.0 | 0.1 | GO:0097031 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
0.0 | 0.5 | GO:0007597 | blood coagulation, intrinsic pathway(GO:0007597) |
0.0 | 0.2 | GO:0031670 | cellular response to nutrient(GO:0031670) |
0.0 | 0.0 | GO:0060831 | smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021910) smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:0060831) |
0.0 | 0.5 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
0.0 | 0.2 | GO:0006528 | asparagine metabolic process(GO:0006528) |
0.0 | 0.0 | GO:0001820 | serotonin secretion(GO:0001820) |
0.0 | 0.1 | GO:0006883 | cellular sodium ion homeostasis(GO:0006883) |
0.0 | 0.1 | GO:0034214 | protein hexamerization(GO:0034214) |
0.0 | 0.6 | GO:0035036 | binding of sperm to zona pellucida(GO:0007339) sperm-egg recognition(GO:0035036) |
0.0 | 0.1 | GO:0002076 | osteoblast development(GO:0002076) |
0.0 | 0.0 | GO:0003211 | cardiac chamber formation(GO:0003207) cardiac ventricle formation(GO:0003211) |
0.0 | 0.1 | GO:0046952 | ketone body catabolic process(GO:0046952) |
0.0 | 0.4 | GO:0051350 | negative regulation of adenylate cyclase activity(GO:0007194) negative regulation of cyclase activity(GO:0031280) negative regulation of lyase activity(GO:0051350) |
0.0 | 0.1 | GO:0032610 | interleukin-1 alpha production(GO:0032610) regulation of interleukin-1 alpha production(GO:0032650) positive regulation of interleukin-1 alpha production(GO:0032730) |
0.0 | 0.2 | GO:0006600 | creatine metabolic process(GO:0006600) |
0.0 | 0.0 | GO:0014055 | acetylcholine secretion, neurotransmission(GO:0014055) regulation of acetylcholine secretion, neurotransmission(GO:0014056) acetylcholine secretion(GO:0061526) |
0.0 | 0.3 | GO:0046928 | regulation of neurotransmitter secretion(GO:0046928) |
0.0 | 0.1 | GO:0016081 | synaptic vesicle docking(GO:0016081) |
0.0 | 0.1 | GO:0007021 | tubulin complex assembly(GO:0007021) |
0.0 | 0.3 | GO:0006611 | protein export from nucleus(GO:0006611) |
0.0 | 0.1 | GO:0006301 | postreplication repair(GO:0006301) |
0.0 | 0.3 | GO:0032781 | positive regulation of ATPase activity(GO:0032781) |
0.0 | 0.2 | GO:0009304 | tRNA transcription(GO:0009304) |
0.0 | 0.1 | GO:0051459 | corticotropin secretion(GO:0051458) regulation of corticotropin secretion(GO:0051459) positive regulation of corticotropin secretion(GO:0051461) |
0.0 | 0.1 | GO:0051953 | negative regulation of organic acid transport(GO:0032891) negative regulation of amine transport(GO:0051953) negative regulation of amino acid transport(GO:0051956) |
0.0 | 0.1 | GO:0050706 | regulation of interleukin-1 beta secretion(GO:0050706) |
0.0 | 0.1 | GO:0051546 | keratinocyte migration(GO:0051546) |
0.0 | 1.5 | GO:1902807 | negative regulation of cell cycle G1/S phase transition(GO:1902807) negative regulation of G1/S transition of mitotic cell cycle(GO:2000134) |
0.0 | 0.1 | GO:0010155 | regulation of proton transport(GO:0010155) |
0.0 | 0.4 | GO:0000216 | obsolete M/G1 transition of mitotic cell cycle(GO:0000216) |
0.0 | 0.0 | GO:0006900 | membrane budding(GO:0006900) |
0.0 | 0.2 | GO:0045670 | regulation of osteoclast differentiation(GO:0045670) |
0.0 | 0.6 | GO:0032480 | negative regulation of type I interferon production(GO:0032480) |
0.0 | 1.9 | GO:0007265 | Ras protein signal transduction(GO:0007265) |
0.0 | 0.2 | GO:0051457 | maintenance of protein location in nucleus(GO:0051457) |
0.0 | 0.1 | GO:0043248 | proteasome assembly(GO:0043248) |
0.0 | 0.0 | GO:0048711 | positive regulation of astrocyte differentiation(GO:0048711) |
0.0 | 0.0 | GO:0033160 | positive regulation of protein import into nucleus, translocation(GO:0033160) |
0.0 | 0.6 | GO:0034762 | regulation of transmembrane transport(GO:0034762) |
0.0 | 0.1 | GO:0046940 | nucleoside monophosphate phosphorylation(GO:0046940) |
0.0 | 0.2 | GO:0042509 | regulation of tyrosine phosphorylation of STAT protein(GO:0042509) |
0.0 | 0.1 | GO:0009134 | nucleoside diphosphate catabolic process(GO:0009134) ribonucleoside diphosphate catabolic process(GO:0009191) |
0.0 | 0.1 | GO:0032988 | ribonucleoprotein complex disassembly(GO:0032988) |
0.0 | 0.0 | GO:0032527 | protein exit from endoplasmic reticulum(GO:0032527) |
0.0 | 0.1 | GO:0001961 | positive regulation of cytokine-mediated signaling pathway(GO:0001961) |
0.0 | 0.3 | GO:0046519 | sphingoid metabolic process(GO:0046519) |
0.0 | 0.3 | GO:0006554 | lysine metabolic process(GO:0006553) lysine catabolic process(GO:0006554) |
0.0 | 0.0 | GO:0000305 | response to oxygen radical(GO:0000305) |
0.0 | 1.3 | GO:0006921 | cellular component disassembly involved in execution phase of apoptosis(GO:0006921) execution phase of apoptosis(GO:0097194) |
0.0 | 0.1 | GO:0051324 | prophase(GO:0051324) |
0.0 | 0.4 | GO:0022616 | DNA strand elongation(GO:0022616) |
0.0 | 0.1 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
0.0 | 0.1 | GO:0040023 | establishment of nucleus localization(GO:0040023) |
0.0 | 0.2 | GO:0048384 | retinoic acid receptor signaling pathway(GO:0048384) |
0.0 | 0.2 | GO:0018198 | peptidyl-cysteine modification(GO:0018198) |
0.0 | 6.5 | GO:0006397 | mRNA processing(GO:0006397) |
0.0 | 0.1 | GO:0070365 | hepatocyte differentiation(GO:0070365) regulation of hepatocyte differentiation(GO:0070366) |
0.0 | 0.0 | GO:0075733 | multi-organism transport(GO:0044766) transport of virus(GO:0046794) intracellular transport of virus(GO:0075733) multi-organism localization(GO:1902579) multi-organism intracellular transport(GO:1902583) |
0.0 | 0.1 | GO:0010800 | positive regulation of peptidyl-threonine phosphorylation(GO:0010800) |
0.0 | 0.0 | GO:0035587 | purinergic receptor signaling pathway(GO:0035587) |
0.0 | 0.2 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
0.0 | 0.2 | GO:0001892 | embryonic placenta development(GO:0001892) |
0.0 | 0.2 | GO:0008105 | asymmetric protein localization(GO:0008105) |
0.0 | 0.1 | GO:0030309 | poly-N-acetyllactosamine metabolic process(GO:0030309) |
0.0 | 0.1 | GO:0040009 | regulation of growth rate(GO:0040009) |
0.0 | 0.1 | GO:0019048 | modulation by virus of host morphology or physiology(GO:0019048) |
0.0 | 0.5 | GO:0043966 | histone H3 acetylation(GO:0043966) |
0.0 | 1.0 | GO:0006120 | mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
0.0 | 0.0 | GO:0032616 | interleukin-13 production(GO:0032616) |
0.0 | 1.0 | GO:0034339 | obsolete regulation of transcription from RNA polymerase II promoter by nuclear hormone receptor(GO:0034339) |
0.0 | 0.2 | GO:0032008 | positive regulation of TOR signaling(GO:0032008) |
0.0 | 0.3 | GO:0007140 | male meiosis(GO:0007140) |
0.0 | 0.1 | GO:1900087 | traversing start control point of mitotic cell cycle(GO:0007089) positive regulation of G1/S transition of mitotic cell cycle(GO:1900087) positive regulation of cell cycle G1/S phase transition(GO:1902808) |
0.0 | 0.0 | GO:0072210 | metanephric nephron development(GO:0072210) |
0.0 | 0.4 | GO:0016254 | preassembly of GPI anchor in ER membrane(GO:0016254) |
0.0 | 0.1 | GO:0071569 | protein ufmylation(GO:0071569) |
0.0 | 0.1 | GO:0042726 | flavin-containing compound metabolic process(GO:0042726) |
0.0 | 0.3 | GO:0033209 | tumor necrosis factor-mediated signaling pathway(GO:0033209) |
0.0 | 0.0 | GO:0003032 | detection of oxygen(GO:0003032) |
0.0 | 0.1 | GO:0045979 | positive regulation of nucleotide catabolic process(GO:0030813) positive regulation of glycolytic process(GO:0045821) positive regulation of nucleoside metabolic process(GO:0045979) positive regulation of cofactor metabolic process(GO:0051194) positive regulation of coenzyme metabolic process(GO:0051197) positive regulation of ATP metabolic process(GO:1903580) |
0.0 | 0.0 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
0.0 | 0.6 | GO:0071805 | cellular potassium ion transport(GO:0071804) potassium ion transmembrane transport(GO:0071805) |
0.0 | 2.3 | GO:0006415 | translational termination(GO:0006415) |
0.0 | 0.1 | GO:0022408 | negative regulation of cell-cell adhesion(GO:0022408) |
0.0 | 0.0 | GO:0033194 | response to hydroperoxide(GO:0033194) |
0.0 | 0.0 | GO:0044803 | multi-organism membrane organization(GO:0044803) |
0.0 | 0.0 | GO:0033033 | negative regulation of myeloid cell apoptotic process(GO:0033033) |
0.0 | 0.0 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
0.0 | 0.3 | GO:0006283 | transcription-coupled nucleotide-excision repair(GO:0006283) |
0.0 | 0.1 | GO:0010288 | response to lead ion(GO:0010288) |
0.0 | 0.2 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.0 | 0.1 | GO:0034105 | positive regulation of tissue remodeling(GO:0034105) |
0.0 | 0.0 | GO:0008631 | intrinsic apoptotic signaling pathway in response to oxidative stress(GO:0008631) cell death in response to oxidative stress(GO:0036473) |
0.0 | 0.1 | GO:0030147 | obsolete natriuresis(GO:0030147) |
0.0 | 0.1 | GO:0046173 | polyol biosynthetic process(GO:0046173) |
0.0 | 0.0 | GO:0001832 | blastocyst growth(GO:0001832) |
0.0 | 0.1 | GO:0046689 | response to mercury ion(GO:0046689) |
0.0 | 0.6 | GO:0015682 | ferric iron transport(GO:0015682) transferrin transport(GO:0033572) trivalent inorganic cation transport(GO:0072512) |
0.0 | 0.1 | GO:0051552 | flavone metabolic process(GO:0051552) |
0.0 | 0.2 | GO:0048536 | spleen development(GO:0048536) |
0.0 | 0.1 | GO:0008612 | peptidyl-lysine modification to peptidyl-hypusine(GO:0008612) |
0.0 | 0.0 | GO:0001553 | luteinization(GO:0001553) |
0.0 | 0.0 | GO:0006515 | misfolded or incompletely synthesized protein catabolic process(GO:0006515) |
0.0 | 0.2 | GO:1901663 | quinone biosynthetic process(GO:1901663) |
0.0 | 0.0 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
0.0 | 0.3 | GO:0008380 | RNA splicing(GO:0008380) |
0.0 | 0.2 | GO:0006385 | transcription elongation from RNA polymerase III promoter(GO:0006385) termination of RNA polymerase III transcription(GO:0006386) |
0.0 | 0.0 | GO:0045746 | negative regulation of Notch signaling pathway(GO:0045746) |
0.0 | 0.1 | GO:0042921 | glucocorticoid receptor signaling pathway(GO:0042921) |
0.0 | 0.1 | GO:0016075 | rRNA catabolic process(GO:0016075) |
0.0 | 0.2 | GO:0051568 | histone H3-K4 methylation(GO:0051568) |
0.0 | 0.1 | GO:1901186 | positive regulation of epidermal growth factor receptor signaling pathway(GO:0045742) positive regulation of ERBB signaling pathway(GO:1901186) |
0.0 | 0.0 | GO:0072332 | intrinsic apoptotic signaling pathway by p53 class mediator(GO:0072332) |
0.0 | 0.2 | GO:0051928 | positive regulation of calcium ion transport(GO:0051928) |
0.0 | 0.3 | GO:1903305 | regulation of regulated secretory pathway(GO:1903305) |
0.0 | 0.0 | GO:0048505 | regulation of development, heterochronic(GO:0040034) regulation of timing of cell differentiation(GO:0048505) |
0.0 | 0.0 | GO:0018126 | protein hydroxylation(GO:0018126) |
0.0 | 0.0 | GO:0072662 | protein targeting to peroxisome(GO:0006625) protein localization to peroxisome(GO:0072662) establishment of protein localization to peroxisome(GO:0072663) |
0.0 | 0.2 | GO:0042044 | fluid transport(GO:0042044) |
0.0 | 0.2 | GO:0001539 | cilium or flagellum-dependent cell motility(GO:0001539) |
0.0 | 0.1 | GO:0048069 | eye pigmentation(GO:0048069) |
0.0 | 0.0 | GO:0015802 | basic amino acid transport(GO:0015802) |
0.0 | 1.3 | GO:0006364 | rRNA processing(GO:0006364) |
0.0 | 0.0 | GO:0031297 | replication fork processing(GO:0031297) |
0.0 | 0.1 | GO:0015791 | polyol transport(GO:0015791) |
0.0 | 0.4 | GO:0006414 | translational elongation(GO:0006414) |
0.0 | 0.0 | GO:0030146 | obsolete diuresis(GO:0030146) |
0.0 | 0.0 | GO:0090083 | regulation of inclusion body assembly(GO:0090083) |
0.0 | 0.3 | GO:0006904 | vesicle docking involved in exocytosis(GO:0006904) |
0.0 | 0.1 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
0.0 | 0.7 | GO:0006695 | cholesterol biosynthetic process(GO:0006695) |
0.0 | 0.0 | GO:0050847 | progesterone receptor signaling pathway(GO:0050847) |
0.0 | 0.1 | GO:0002098 | tRNA wobble base modification(GO:0002097) tRNA wobble uridine modification(GO:0002098) tRNA thio-modification(GO:0034227) |
0.0 | 0.4 | GO:0030835 | actin filament depolymerization(GO:0030042) regulation of actin filament depolymerization(GO:0030834) negative regulation of actin filament depolymerization(GO:0030835) |
0.0 | 0.1 | GO:0051875 | pigment granule localization(GO:0051875) |
0.0 | 0.1 | GO:0061077 | chaperone-mediated protein folding(GO:0061077) |
0.0 | 0.0 | GO:0022037 | metencephalon development(GO:0022037) |
0.0 | 0.2 | GO:0000050 | urea cycle(GO:0000050) |
0.0 | 0.0 | GO:0015742 | alpha-ketoglutarate transport(GO:0015742) |
0.0 | 0.1 | GO:0050974 | detection of mechanical stimulus involved in sensory perception of sound(GO:0050910) detection of mechanical stimulus involved in sensory perception(GO:0050974) |
0.0 | 0.1 | GO:0009812 | flavonoid metabolic process(GO:0009812) |
0.0 | 0.1 | GO:0061462 | protein targeting to lysosome(GO:0006622) protein targeting to vacuole(GO:0006623) protein localization to lysosome(GO:0061462) protein localization to vacuole(GO:0072665) establishment of protein localization to vacuole(GO:0072666) |
0.0 | 0.0 | GO:0072502 | cellular phosphate ion homeostasis(GO:0030643) cellular divalent inorganic anion homeostasis(GO:0072501) cellular trivalent inorganic anion homeostasis(GO:0072502) |
0.0 | 0.1 | GO:0009070 | serine family amino acid biosynthetic process(GO:0009070) |
0.0 | 0.1 | GO:0006561 | proline metabolic process(GO:0006560) proline biosynthetic process(GO:0006561) |
0.0 | 0.0 | GO:0046640 | regulation of alpha-beta T cell proliferation(GO:0046640) |
0.0 | 0.2 | GO:0043967 | histone H4 acetylation(GO:0043967) |
0.0 | 0.0 | GO:0030857 | negative regulation of epithelial cell differentiation(GO:0030857) |
0.0 | 0.0 | GO:0042428 | serotonin metabolic process(GO:0042428) primary amino compound metabolic process(GO:1901160) |
0.0 | 0.1 | GO:0046605 | regulation of centrosome cycle(GO:0046605) |
0.0 | 0.0 | GO:0071501 | response to sterol depletion(GO:0006991) SREBP signaling pathway(GO:0032933) cellular response to sterol depletion(GO:0071501) |
0.0 | 0.1 | GO:0007031 | peroxisome organization(GO:0007031) |
0.0 | 0.1 | GO:0034110 | regulation of homotypic cell-cell adhesion(GO:0034110) |
0.0 | 0.2 | GO:0006305 | DNA alkylation(GO:0006305) DNA methylation(GO:0006306) |
0.0 | 0.1 | GO:0070972 | protein localization to endoplasmic reticulum(GO:0070972) |
0.0 | 0.0 | GO:0016576 | histone dephosphorylation(GO:0016576) |
0.0 | 0.1 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.0 | 0.3 | GO:0006004 | fucose metabolic process(GO:0006004) |
0.0 | 0.0 | GO:0071503 | response to heparin(GO:0071503) |
0.0 | 0.6 | GO:0051028 | mRNA transport(GO:0051028) |
0.0 | 0.0 | GO:0042088 | T-helper 1 type immune response(GO:0042088) |
0.0 | 0.1 | GO:0045010 | actin nucleation(GO:0045010) |
0.0 | 0.1 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
0.0 | 0.1 | GO:0035050 | embryonic heart tube development(GO:0035050) |
0.0 | 0.1 | GO:0051131 | chaperone-mediated protein complex assembly(GO:0051131) |
0.0 | 0.1 | GO:0015886 | heme transport(GO:0015886) |
0.0 | 0.1 | GO:0015985 | energy coupled proton transport, down electrochemical gradient(GO:0015985) ATP synthesis coupled proton transport(GO:0015986) |
0.0 | 0.1 | GO:0050962 | detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
0.0 | 0.4 | GO:0006493 | protein O-linked glycosylation(GO:0006493) |
0.0 | 0.1 | GO:0007520 | syncytium formation by plasma membrane fusion(GO:0000768) syncytium formation(GO:0006949) myoblast fusion(GO:0007520) |
0.0 | 0.6 | GO:0045665 | negative regulation of neuron differentiation(GO:0045665) |
0.0 | 0.1 | GO:0042462 | eye photoreceptor cell development(GO:0042462) |
0.0 | 0.1 | GO:0007350 | blastoderm segmentation(GO:0007350) |
0.0 | 0.1 | GO:0006477 | protein sulfation(GO:0006477) |
0.0 | 0.0 | GO:0020027 | hemoglobin metabolic process(GO:0020027) |
0.0 | 0.1 | GO:0033138 | positive regulation of peptidyl-serine phosphorylation(GO:0033138) |
0.0 | 0.0 | GO:0042819 | pyridoxine metabolic process(GO:0008614) pyridoxine biosynthetic process(GO:0008615) vitamin B6 metabolic process(GO:0042816) vitamin B6 biosynthetic process(GO:0042819) |
0.0 | 0.0 | GO:0070233 | negative regulation of T cell apoptotic process(GO:0070233) |
0.0 | 0.6 | GO:0006367 | transcription initiation from RNA polymerase II promoter(GO:0006367) |
0.0 | 0.3 | GO:0051092 | positive regulation of NF-kappaB transcription factor activity(GO:0051092) |
0.0 | 0.1 | GO:0006044 | N-acetylglucosamine metabolic process(GO:0006044) |
0.0 | 0.4 | GO:0007422 | peripheral nervous system development(GO:0007422) |
0.0 | 0.3 | GO:0044782 | cilium organization(GO:0044782) |
0.0 | 0.0 | GO:0001302 | replicative cell aging(GO:0001302) |
0.0 | 0.5 | GO:0022904 | respiratory electron transport chain(GO:0022904) |
0.0 | 3.1 | GO:0006412 | translation(GO:0006412) |
0.0 | 0.0 | GO:0050702 | interleukin-1 beta secretion(GO:0050702) |
0.0 | 0.0 | GO:0051919 | positive regulation of fibrinolysis(GO:0051919) |
0.0 | 0.1 | GO:0030148 | sphingolipid biosynthetic process(GO:0030148) |
0.0 | 0.4 | GO:0060337 | type I interferon signaling pathway(GO:0060337) cellular response to type I interferon(GO:0071357) |
0.0 | 0.1 | GO:0006783 | heme biosynthetic process(GO:0006783) |
0.0 | 0.1 | GO:0030488 | tRNA methylation(GO:0030488) |
0.0 | 0.1 | GO:0043171 | peptide catabolic process(GO:0043171) |
0.0 | 0.0 | GO:0032025 | response to cobalt ion(GO:0032025) |
0.0 | 0.0 | GO:0051095 | regulation of helicase activity(GO:0051095) positive regulation of helicase activity(GO:0051096) |
0.0 | 0.1 | GO:0007099 | centriole replication(GO:0007099) centriole assembly(GO:0098534) |
0.0 | 1.2 | GO:0006333 | chromatin assembly or disassembly(GO:0006333) |
0.0 | 0.1 | GO:0045116 | protein neddylation(GO:0045116) |
0.0 | 0.1 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
0.0 | 0.0 | GO:0045110 | intermediate filament bundle assembly(GO:0045110) |
0.0 | 0.1 | GO:0006857 | oligopeptide transport(GO:0006857) |
0.0 | 0.0 | GO:0071356 | cellular response to tumor necrosis factor(GO:0071356) |
0.0 | 0.0 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
0.0 | 0.1 | GO:0010669 | epithelial structure maintenance(GO:0010669) maintenance of gastrointestinal epithelium(GO:0030277) |
0.0 | 0.0 | GO:0018216 | peptidyl-arginine methylation(GO:0018216) histone H4-R3 methylation(GO:0043985) |
0.0 | 0.0 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
0.0 | 0.2 | GO:0007076 | mitotic chromosome condensation(GO:0007076) |
0.0 | 0.2 | GO:0030317 | sperm motility(GO:0030317) |
0.0 | 0.0 | GO:0042178 | xenobiotic catabolic process(GO:0042178) |
0.0 | 0.0 | GO:1904936 | interneuron migration from the subpallium to the cortex(GO:0021830) cerebral cortex GABAergic interneuron migration(GO:0021853) cerebral cortex GABAergic interneuron development(GO:0021894) interneuron migration(GO:1904936) |
0.0 | 0.0 | GO:0003338 | metanephros morphogenesis(GO:0003338) |
0.0 | 0.1 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
0.0 | 0.0 | GO:0046621 | negative regulation of organ growth(GO:0046621) |
0.0 | 0.1 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
0.0 | 0.0 | GO:0050435 | beta-amyloid metabolic process(GO:0050435) |
0.0 | 0.0 | GO:0042987 | amyloid precursor protein catabolic process(GO:0042987) |
0.0 | 0.0 | GO:0001881 | receptor recycling(GO:0001881) |
0.0 | 0.0 | GO:0097028 | myeloid dendritic cell differentiation(GO:0043011) dendritic cell differentiation(GO:0097028) |
0.0 | 0.0 | GO:0007252 | I-kappaB phosphorylation(GO:0007252) |
0.0 | 0.0 | GO:0051703 | social behavior(GO:0035176) intraspecies interaction between organisms(GO:0051703) |
0.0 | 0.0 | GO:0060684 | epithelial-mesenchymal cell signaling(GO:0060684) |
0.0 | 0.0 | GO:0014888 | striated muscle adaptation(GO:0014888) |
0.0 | 0.6 | GO:0006399 | tRNA metabolic process(GO:0006399) tRNA processing(GO:0008033) |
0.0 | 0.2 | GO:0018208 | peptidyl-proline modification(GO:0018208) |
0.0 | 0.1 | GO:0006544 | glycine metabolic process(GO:0006544) |
0.0 | 0.0 | GO:0032878 | regulation of establishment or maintenance of cell polarity(GO:0032878) |
0.0 | 1.0 | GO:0043087 | regulation of GTPase activity(GO:0043087) |
0.0 | 0.5 | GO:0000209 | protein polyubiquitination(GO:0000209) |
0.0 | 0.0 | GO:0002724 | regulation of T cell cytokine production(GO:0002724) |
0.0 | 0.0 | GO:0044240 | multicellular organism lipid catabolic process(GO:0044240) |
0.0 | 0.1 | GO:0007635 | chemosensory behavior(GO:0007635) |
0.0 | 0.3 | GO:0035966 | response to unfolded protein(GO:0006986) response to topologically incorrect protein(GO:0035966) |
0.0 | 0.1 | GO:0016180 | snRNA processing(GO:0016180) |
0.0 | 0.1 | GO:0032024 | positive regulation of insulin secretion(GO:0032024) |
0.0 | 0.0 | GO:0006884 | cell volume homeostasis(GO:0006884) |
0.0 | 0.1 | GO:0060359 | response to ammonium ion(GO:0060359) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.7 | 2.0 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
0.3 | 1.0 | GO:0070022 | transforming growth factor beta receptor homodimeric complex(GO:0070022) |
0.3 | 1.0 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.3 | 1.0 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.3 | 2.4 | GO:0001891 | phagocytic cup(GO:0001891) |
0.2 | 0.5 | GO:0031932 | TORC2 complex(GO:0031932) |
0.2 | 3.3 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.2 | 2.1 | GO:0042101 | T cell receptor complex(GO:0042101) |
0.2 | 1.3 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
0.2 | 3.1 | GO:0016514 | SWI/SNF complex(GO:0016514) |
0.2 | 0.8 | GO:0005667 | transcription factor complex(GO:0005667) |
0.2 | 2.4 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.2 | 0.7 | GO:0034992 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.2 | 0.5 | GO:0000942 | condensed nuclear chromosome outer kinetochore(GO:0000942) |
0.2 | 0.2 | GO:0000785 | chromatin(GO:0000785) |
0.2 | 1.0 | GO:0005883 | neurofilament(GO:0005883) |
0.2 | 0.5 | GO:0032444 | activin responsive factor complex(GO:0032444) |
0.2 | 1.9 | GO:0001772 | immunological synapse(GO:0001772) |
0.2 | 1.0 | GO:0031264 | death-inducing signaling complex(GO:0031264) |
0.2 | 0.6 | GO:0000300 | obsolete peripheral to membrane of membrane fraction(GO:0000300) |
0.2 | 1.7 | GO:0035631 | CD40 receptor complex(GO:0035631) |
0.2 | 0.5 | GO:0071942 | XPC complex(GO:0071942) |
0.1 | 0.6 | GO:0033179 | proton-transporting V-type ATPase, V0 domain(GO:0033179) |
0.1 | 1.4 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.1 | 0.1 | GO:0030686 | 90S preribosome(GO:0030686) |
0.1 | 1.8 | GO:0043209 | myelin sheath(GO:0043209) |
0.1 | 0.5 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.1 | 0.4 | GO:0031904 | endosome lumen(GO:0031904) |
0.1 | 0.6 | GO:0001931 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.1 | 0.4 | GO:0030895 | apolipoprotein B mRNA editing enzyme complex(GO:0030895) |
0.1 | 0.2 | GO:0071664 | catenin-TCF7L2 complex(GO:0071664) |
0.1 | 3.9 | GO:0030175 | filopodium(GO:0030175) |
0.1 | 0.5 | GO:0005827 | polar microtubule(GO:0005827) |
0.1 | 2.5 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
0.1 | 0.6 | GO:0000791 | euchromatin(GO:0000791) |
0.1 | 0.6 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
0.1 | 0.1 | GO:0042575 | DNA polymerase complex(GO:0042575) |
0.1 | 0.2 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.1 | 0.3 | GO:0070938 | actomyosin contractile ring(GO:0005826) contractile ring(GO:0070938) |
0.1 | 0.4 | GO:0030061 | mitochondrial crista(GO:0030061) |
0.1 | 0.3 | GO:0008540 | proteasome regulatory particle, base subcomplex(GO:0008540) |
0.1 | 0.2 | GO:0045298 | tubulin complex(GO:0045298) |
0.1 | 0.3 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.1 | 1.3 | GO:0033276 | transcription factor TFTC complex(GO:0033276) |
0.1 | 0.3 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
0.1 | 2.0 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.1 | 0.6 | GO:0019907 | cyclin-dependent protein kinase activating kinase holoenzyme complex(GO:0019907) |
0.1 | 4.2 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
0.1 | 0.4 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
0.1 | 0.3 | GO:0019908 | nuclear cyclin-dependent protein kinase holoenzyme complex(GO:0019908) |
0.1 | 1.7 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.1 | 0.3 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
0.1 | 0.4 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
0.1 | 0.5 | GO:0070688 | MLL5-L complex(GO:0070688) |
0.1 | 0.5 | GO:0000275 | mitochondrial proton-transporting ATP synthase complex, catalytic core F(1)(GO:0000275) |
0.1 | 0.2 | GO:0071565 | nBAF complex(GO:0071565) |
0.1 | 0.3 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
0.1 | 1.5 | GO:0030530 | obsolete heterogeneous nuclear ribonucleoprotein complex(GO:0030530) |
0.1 | 0.4 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
0.1 | 0.7 | GO:0061202 | clathrin-sculpted gamma-aminobutyric acid transport vesicle(GO:0061200) clathrin-sculpted gamma-aminobutyric acid transport vesicle membrane(GO:0061202) |
0.1 | 0.4 | GO:0032590 | dendrite membrane(GO:0032590) |
0.1 | 0.9 | GO:0032156 | septin complex(GO:0031105) septin cytoskeleton(GO:0032156) |
0.1 | 0.2 | GO:0072487 | MSL complex(GO:0072487) |
0.1 | 0.2 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
0.1 | 0.4 | GO:0000153 | cytoplasmic ubiquitin ligase complex(GO:0000153) |
0.1 | 0.2 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.1 | 0.5 | GO:0031464 | Cul4A-RING E3 ubiquitin ligase complex(GO:0031464) |
0.1 | 0.5 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
0.1 | 0.1 | GO:0060199 | clathrin-sculpted glutamate transport vesicle(GO:0060199) clathrin-sculpted glutamate transport vesicle membrane(GO:0060203) |
0.1 | 0.1 | GO:0045261 | proton-transporting ATP synthase complex, catalytic core F(1)(GO:0045261) |
0.1 | 0.1 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.1 | 0.2 | GO:0032279 | asymmetric synapse(GO:0032279) neuron to neuron synapse(GO:0098984) |
0.1 | 0.8 | GO:0090533 | cation-transporting ATPase complex(GO:0090533) |
0.1 | 0.6 | GO:0042589 | zymogen granule membrane(GO:0042589) |
0.1 | 0.2 | GO:0005863 | striated muscle myosin thick filament(GO:0005863) |
0.1 | 0.2 | GO:0001940 | male pronucleus(GO:0001940) |
0.1 | 0.5 | GO:1904949 | ATPase dependent transmembrane transport complex(GO:0098533) ATPase complex(GO:1904949) |
0.1 | 2.2 | GO:0016592 | mediator complex(GO:0016592) |
0.1 | 0.1 | GO:0030870 | Mre11 complex(GO:0030870) |
0.1 | 0.3 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.1 | 0.3 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.1 | 1.3 | GO:0034361 | very-low-density lipoprotein particle(GO:0034361) triglyceride-rich lipoprotein particle(GO:0034385) |
0.1 | 0.8 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
0.1 | 0.3 | GO:0000242 | pericentriolar material(GO:0000242) |
0.1 | 0.3 | GO:0031229 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) nuclear membrane part(GO:0044453) |
0.1 | 0.7 | GO:0016471 | vacuolar proton-transporting V-type ATPase complex(GO:0016471) |
0.1 | 1.2 | GO:0005844 | polysome(GO:0005844) |
0.1 | 0.1 | GO:0045240 | dihydrolipoyl dehydrogenase complex(GO:0045240) |
0.1 | 0.3 | GO:0000346 | transcription export complex(GO:0000346) |
0.1 | 0.1 | GO:0038201 | TOR complex(GO:0038201) |
0.1 | 0.3 | GO:0016589 | NURF complex(GO:0016589) |
0.1 | 0.4 | GO:0005838 | proteasome regulatory particle(GO:0005838) |
0.1 | 1.9 | GO:0005626 | obsolete insoluble fraction(GO:0005626) |
0.1 | 0.2 | GO:0016939 | kinesin II complex(GO:0016939) |
0.1 | 0.5 | GO:0045120 | pronucleus(GO:0045120) |
0.1 | 0.9 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
0.1 | 1.2 | GO:0031519 | PcG protein complex(GO:0031519) |
0.1 | 0.1 | GO:0070852 | cell body fiber(GO:0070852) |
0.1 | 0.7 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
0.1 | 0.3 | GO:0070776 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
0.1 | 0.3 | GO:0030062 | mitochondrial tricarboxylic acid cycle enzyme complex(GO:0030062) |
0.1 | 0.5 | GO:0032838 | cell projection cytoplasm(GO:0032838) |
0.1 | 0.2 | GO:0042825 | MHC class I peptide loading complex(GO:0042824) TAP complex(GO:0042825) |
0.1 | 0.4 | GO:0042382 | paraspeckles(GO:0042382) |
0.1 | 0.2 | GO:0071818 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
0.1 | 7.0 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.1 | 1.0 | GO:0005637 | nuclear inner membrane(GO:0005637) |
0.1 | 0.4 | GO:0090576 | RNA polymerase III transcription factor complex(GO:0090576) |
0.1 | 0.3 | GO:0000276 | mitochondrial proton-transporting ATP synthase complex, coupling factor F(o)(GO:0000276) |
0.1 | 0.9 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.1 | 0.3 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.1 | 0.1 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
0.1 | 0.2 | GO:0001652 | granular component(GO:0001652) |
0.1 | 0.4 | GO:0034451 | centriolar satellite(GO:0034451) |
0.1 | 0.2 | GO:0071438 | invadopodium membrane(GO:0071438) |
0.1 | 0.2 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
0.1 | 0.2 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
0.1 | 0.2 | GO:0005638 | lamin filament(GO:0005638) |
0.1 | 0.3 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
0.1 | 0.2 | GO:0034362 | low-density lipoprotein particle(GO:0034362) |
0.1 | 0.3 | GO:0005869 | dynactin complex(GO:0005869) |
0.1 | 0.3 | GO:0048500 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) signal recognition particle(GO:0048500) |
0.1 | 0.4 | GO:0034464 | BBSome(GO:0034464) |
0.0 | 0.2 | GO:0005753 | mitochondrial proton-transporting ATP synthase complex(GO:0005753) |
0.0 | 3.9 | GO:0048770 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.0 | 0.3 | GO:0031616 | spindle pole centrosome(GO:0031616) |
0.0 | 0.3 | GO:0005682 | U5 snRNP(GO:0005682) |
0.0 | 0.1 | GO:0033185 | mannosyltransferase complex(GO:0031501) dolichol-phosphate-mannose synthase complex(GO:0033185) |
0.0 | 0.1 | GO:0032009 | early phagosome(GO:0032009) |
0.0 | 0.2 | GO:0002080 | acrosomal membrane(GO:0002080) |
0.0 | 0.4 | GO:0005669 | transcription factor TFIID complex(GO:0005669) |
0.0 | 0.6 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
0.0 | 0.0 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.0 | 0.1 | GO:0032059 | bleb(GO:0032059) |
0.0 | 0.1 | GO:0030312 | external encapsulating structure(GO:0030312) external encapsulating structure part(GO:0044462) |
0.0 | 0.5 | GO:0031672 | A band(GO:0031672) |
0.0 | 0.4 | GO:0031080 | nuclear pore outer ring(GO:0031080) |
0.0 | 0.1 | GO:0030056 | hemidesmosome(GO:0030056) |
0.0 | 0.2 | GO:0071546 | pi-body(GO:0071546) |
0.0 | 0.3 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.0 | 2.2 | GO:0016605 | PML body(GO:0016605) |
0.0 | 0.1 | GO:0070188 | obsolete Stn1-Ten1 complex(GO:0070188) |
0.0 | 1.0 | GO:0005689 | U12-type spliceosomal complex(GO:0005689) |
0.0 | 0.2 | GO:0005845 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
0.0 | 0.2 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
0.0 | 0.4 | GO:0008278 | cohesin complex(GO:0008278) |
0.0 | 0.3 | GO:0016585 | obsolete chromatin remodeling complex(GO:0016585) |
0.0 | 0.4 | GO:0005849 | mRNA cleavage factor complex(GO:0005849) |
0.0 | 0.2 | GO:0035145 | exon-exon junction complex(GO:0035145) |
0.0 | 0.5 | GO:0005779 | integral component of peroxisomal membrane(GO:0005779) intrinsic component of peroxisomal membrane(GO:0031231) |
0.0 | 0.1 | GO:0016442 | RISC complex(GO:0016442) RNAi effector complex(GO:0031332) |
0.0 | 1.4 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
0.0 | 0.2 | GO:0000796 | condensin complex(GO:0000796) |
0.0 | 1.8 | GO:0055037 | recycling endosome(GO:0055037) |
0.0 | 0.0 | GO:0031205 | endoplasmic reticulum Sec complex(GO:0031205) |
0.0 | 0.2 | GO:0090545 | NuRD complex(GO:0016581) CHD-type complex(GO:0090545) nuclear transcriptional repressor complex(GO:0090568) |
0.0 | 1.8 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
0.0 | 0.3 | GO:0097525 | spliceosomal snRNP complex(GO:0097525) |
0.0 | 1.2 | GO:0030118 | clathrin coat(GO:0030118) |
0.0 | 0.7 | GO:0043204 | perikaryon(GO:0043204) |
0.0 | 0.3 | GO:0030677 | nucleolar ribonuclease P complex(GO:0005655) ribonuclease P complex(GO:0030677) multimeric ribonuclease P complex(GO:0030681) |
0.0 | 0.9 | GO:0032587 | ruffle membrane(GO:0032587) |
0.0 | 0.3 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
0.0 | 0.2 | GO:0005663 | DNA replication factor C complex(GO:0005663) |
0.0 | 0.1 | GO:0001741 | XY body(GO:0001741) |
0.0 | 0.0 | GO:0005652 | nuclear lamina(GO:0005652) |
0.0 | 0.3 | GO:0042597 | outer membrane-bounded periplasmic space(GO:0030288) periplasmic space(GO:0042597) |
0.0 | 0.3 | GO:0043198 | dendritic shaft(GO:0043198) |
0.0 | 0.5 | GO:0005905 | clathrin-coated pit(GO:0005905) |
0.0 | 0.2 | GO:0070695 | FHF complex(GO:0070695) |
0.0 | 1.3 | GO:0030964 | mitochondrial respiratory chain complex I(GO:0005747) NADH dehydrogenase complex(GO:0030964) respiratory chain complex I(GO:0045271) |
0.0 | 1.6 | GO:0000502 | proteasome complex(GO:0000502) |
0.0 | 0.7 | GO:0019861 | obsolete flagellum(GO:0019861) |
0.0 | 0.1 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
0.0 | 0.3 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.0 | 1.1 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.0 | 0.0 | GO:0071564 | npBAF complex(GO:0071564) |
0.0 | 0.4 | GO:0030864 | cortical actin cytoskeleton(GO:0030864) |
0.0 | 0.1 | GO:0071256 | Sec61 translocon complex(GO:0005784) translocon complex(GO:0071256) |
0.0 | 0.1 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
0.0 | 0.2 | GO:0001917 | photoreceptor inner segment(GO:0001917) |
0.0 | 0.1 | GO:0033177 | proton-transporting two-sector ATPase complex, proton-transporting domain(GO:0033177) |
0.0 | 0.1 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
0.0 | 0.1 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.0 | 0.1 | GO:0005862 | muscle thin filament tropomyosin(GO:0005862) |
0.0 | 0.2 | GO:0005732 | small nucleolar ribonucleoprotein complex(GO:0005732) |
0.0 | 0.3 | GO:0016328 | lateral plasma membrane(GO:0016328) |
0.0 | 0.6 | GO:0015935 | small ribosomal subunit(GO:0015935) |
0.0 | 0.1 | GO:0031082 | BLOC complex(GO:0031082) BLOC-1 complex(GO:0031083) |
0.0 | 0.4 | GO:0044665 | MLL1/2 complex(GO:0044665) MLL1 complex(GO:0071339) |
0.0 | 0.2 | GO:0016461 | unconventional myosin complex(GO:0016461) |
0.0 | 0.4 | GO:0005796 | Golgi lumen(GO:0005796) |
0.0 | 2.4 | GO:0005681 | spliceosomal complex(GO:0005681) |
0.0 | 0.4 | GO:0046930 | pore complex(GO:0046930) |
0.0 | 0.2 | GO:0035097 | methyltransferase complex(GO:0034708) histone methyltransferase complex(GO:0035097) |
0.0 | 0.0 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
0.0 | 0.2 | GO:0005664 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
0.0 | 0.3 | GO:0005640 | nuclear outer membrane(GO:0005640) |
0.0 | 0.5 | GO:0005762 | organellar large ribosomal subunit(GO:0000315) mitochondrial large ribosomal subunit(GO:0005762) |
0.0 | 0.7 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
0.0 | 22.2 | GO:0005730 | nucleolus(GO:0005730) |
0.0 | 0.1 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
0.0 | 0.0 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.0 | 0.1 | GO:0005954 | calcium- and calmodulin-dependent protein kinase complex(GO:0005954) |
0.0 | 0.2 | GO:0097517 | stress fiber(GO:0001725) contractile actin filament bundle(GO:0097517) |
0.0 | 0.1 | GO:0071986 | Ragulator complex(GO:0071986) |
0.0 | 0.6 | GO:0001726 | ruffle(GO:0001726) |
0.0 | 0.1 | GO:0035189 | Rb-E2F complex(GO:0035189) |
0.0 | 1.2 | GO:0005643 | nuclear pore(GO:0005643) |
0.0 | 0.0 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
0.0 | 7.3 | GO:0005768 | endosome(GO:0005768) |
0.0 | 0.3 | GO:0030137 | COPI-coated vesicle(GO:0030137) |
0.0 | 0.0 | GO:0070820 | tertiary granule(GO:0070820) |
0.0 | 0.1 | GO:0042583 | chromaffin granule(GO:0042583) chromaffin granule membrane(GO:0042584) |
0.0 | 0.2 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
0.0 | 0.3 | GO:0034706 | sodium channel complex(GO:0034706) |
0.0 | 0.1 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
0.0 | 0.2 | GO:0005884 | actin filament(GO:0005884) |
0.0 | 0.7 | GO:0000313 | organellar ribosome(GO:0000313) mitochondrial ribosome(GO:0005761) |
0.0 | 74.9 | GO:0005634 | nucleus(GO:0005634) |
0.0 | 0.5 | GO:0005921 | gap junction(GO:0005921) |
0.0 | 0.0 | GO:0071817 | MMXD complex(GO:0071817) |
0.0 | 0.1 | GO:0045179 | apical cortex(GO:0045179) |
0.0 | 0.0 | GO:0033270 | paranode region of axon(GO:0033270) |
0.0 | 0.0 | GO:0031143 | pseudopodium(GO:0031143) |
0.0 | 0.6 | GO:0030286 | dynein complex(GO:0030286) |
0.0 | 0.0 | GO:0030904 | retromer complex(GO:0030904) |
0.0 | 0.4 | GO:0005746 | mitochondrial respiratory chain(GO:0005746) |
0.0 | 1.2 | GO:0034705 | potassium channel complex(GO:0034705) |
0.0 | 1.0 | GO:1990904 | intracellular ribonucleoprotein complex(GO:0030529) ribonucleoprotein complex(GO:1990904) |
0.0 | 1.0 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
0.0 | 0.1 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
0.0 | 0.3 | GO:0009295 | nucleoid(GO:0009295) mitochondrial nucleoid(GO:0042645) |
0.0 | 1.5 | GO:0000323 | lytic vacuole(GO:0000323) lysosome(GO:0005764) |
0.0 | 0.0 | GO:0018995 | host(GO:0018995) host cell part(GO:0033643) host intracellular part(GO:0033646) intracellular region of host(GO:0043656) host cell(GO:0043657) other organism(GO:0044215) other organism cell(GO:0044216) other organism part(GO:0044217) |
0.0 | 0.2 | GO:0042612 | MHC class I protein complex(GO:0042612) |
0.0 | 0.3 | GO:0036064 | ciliary basal body(GO:0036064) |
0.0 | 0.0 | GO:0005787 | signal peptidase complex(GO:0005787) |
0.0 | 0.0 | GO:0005594 | collagen type IX trimer(GO:0005594) |
0.0 | 1.7 | GO:0005743 | mitochondrial inner membrane(GO:0005743) |
0.0 | 6.0 | GO:0005783 | endoplasmic reticulum(GO:0005783) |
0.0 | 1.1 | GO:0048471 | perinuclear region of cytoplasm(GO:0048471) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.5 | 2.4 | GO:0052813 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity(GO:0046934) phosphatidylinositol bisphosphate kinase activity(GO:0052813) |
0.4 | 3.9 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
0.4 | 1.1 | GO:0046935 | 1-phosphatidylinositol-3-kinase regulator activity(GO:0046935) |
0.3 | 1.0 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
0.3 | 1.0 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.3 | 4.9 | GO:0004697 | protein kinase C activity(GO:0004697) |
0.3 | 1.3 | GO:0030284 | estrogen receptor activity(GO:0030284) |
0.3 | 0.9 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.3 | 0.9 | GO:0042608 | T cell receptor binding(GO:0042608) |
0.3 | 1.6 | GO:0016494 | C-X-C chemokine receptor activity(GO:0016494) |
0.3 | 0.8 | GO:0033691 | sialic acid binding(GO:0033691) |
0.3 | 0.8 | GO:0004911 | interleukin-2 receptor activity(GO:0004911) |
0.2 | 1.0 | GO:0015925 | galactosidase activity(GO:0015925) |
0.2 | 0.7 | GO:0047756 | chondroitin 4-sulfotransferase activity(GO:0047756) |
0.2 | 1.6 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
0.2 | 0.9 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) |
0.2 | 2.0 | GO:0034593 | phosphatidylinositol bisphosphate phosphatase activity(GO:0034593) |
0.2 | 0.4 | GO:0000828 | inositol hexakisphosphate kinase activity(GO:0000828) inositol hexakisphosphate 5-kinase activity(GO:0000832) |
0.2 | 2.8 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
0.2 | 0.6 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
0.2 | 0.4 | GO:0016314 | phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity(GO:0016314) |
0.2 | 0.6 | GO:0042156 | obsolete zinc-mediated transcriptional activator activity(GO:0042156) |
0.2 | 0.6 | GO:0031685 | adenosine receptor binding(GO:0031685) |
0.2 | 0.2 | GO:0034481 | chondroitin sulfotransferase activity(GO:0034481) |
0.2 | 1.6 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
0.2 | 0.9 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
0.2 | 2.2 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
0.2 | 0.7 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
0.2 | 0.5 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
0.2 | 1.4 | GO:0003785 | actin monomer binding(GO:0003785) |
0.2 | 1.9 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.2 | 1.0 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
0.2 | 0.5 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
0.2 | 0.5 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
0.2 | 0.5 | GO:0004311 | farnesyltranstransferase activity(GO:0004311) |
0.2 | 0.5 | GO:0004897 | ciliary neurotrophic factor receptor activity(GO:0004897) |
0.2 | 5.9 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.2 | 0.2 | GO:0019958 | C-X-C chemokine binding(GO:0019958) interleukin-8 binding(GO:0019959) |
0.2 | 0.9 | GO:0008266 | poly(U) RNA binding(GO:0008266) |
0.2 | 1.4 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.2 | 0.5 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
0.2 | 0.3 | GO:0043398 | HLH domain binding(GO:0043398) |
0.1 | 0.9 | GO:0070513 | death domain binding(GO:0070513) |
0.1 | 0.4 | GO:0016842 | amidine-lyase activity(GO:0016842) |
0.1 | 2.5 | GO:0008373 | sialyltransferase activity(GO:0008373) |
0.1 | 1.2 | GO:0030332 | cyclin binding(GO:0030332) |
0.1 | 0.4 | GO:0030375 | thyroid hormone receptor coactivator activity(GO:0030375) |
0.1 | 0.4 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
0.1 | 1.9 | GO:0030159 | receptor signaling complex scaffold activity(GO:0030159) |
0.1 | 0.7 | GO:0034452 | dynactin binding(GO:0034452) |
0.1 | 0.4 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
0.1 | 0.9 | GO:0016778 | diphosphotransferase activity(GO:0016778) |
0.1 | 0.6 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
0.1 | 0.4 | GO:0031628 | opioid receptor binding(GO:0031628) |
0.1 | 3.5 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.1 | 1.7 | GO:0031593 | polyubiquitin binding(GO:0031593) |
0.1 | 3.1 | GO:0001608 | G-protein coupled nucleotide receptor activity(GO:0001608) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
0.1 | 0.8 | GO:0050733 | RS domain binding(GO:0050733) |
0.1 | 0.5 | GO:0055106 | ligase regulator activity(GO:0055103) ubiquitin-protein transferase regulator activity(GO:0055106) |
0.1 | 0.4 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
0.1 | 0.4 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
0.1 | 0.9 | GO:0008494 | translation activator activity(GO:0008494) |
0.1 | 0.5 | GO:0005315 | inorganic phosphate transmembrane transporter activity(GO:0005315) |
0.1 | 0.4 | GO:0000064 | L-ornithine transmembrane transporter activity(GO:0000064) |
0.1 | 0.6 | GO:0060229 | lipase activator activity(GO:0060229) |
0.1 | 1.1 | GO:0005338 | nucleotide-sugar transmembrane transporter activity(GO:0005338) |
0.1 | 2.5 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.1 | 0.5 | GO:0004032 | alditol:NADP+ 1-oxidoreductase activity(GO:0004032) |
0.1 | 1.4 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
0.1 | 1.1 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.1 | 0.6 | GO:0001637 | G-protein coupled chemoattractant receptor activity(GO:0001637) chemokine receptor activity(GO:0004950) |
0.1 | 5.8 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.1 | 1.6 | GO:0017017 | MAP kinase tyrosine/serine/threonine phosphatase activity(GO:0017017) |
0.1 | 0.1 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
0.1 | 0.4 | GO:0005113 | patched binding(GO:0005113) |
0.1 | 0.2 | GO:0042392 | sphingosine-1-phosphate phosphatase activity(GO:0042392) |
0.1 | 0.8 | GO:0008440 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) inositol trisphosphate kinase activity(GO:0051766) |
0.1 | 0.1 | GO:0035197 | siRNA binding(GO:0035197) |
0.1 | 0.2 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
0.1 | 0.6 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
0.1 | 0.9 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
0.1 | 3.0 | GO:0001104 | RNA polymerase II transcription cofactor activity(GO:0001104) |
0.1 | 0.3 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
0.1 | 0.3 | GO:0050265 | RNA uridylyltransferase activity(GO:0050265) |
0.1 | 1.1 | GO:0015278 | calcium-release channel activity(GO:0015278) ligand-gated calcium channel activity(GO:0099604) |
0.1 | 0.4 | GO:0032454 | histone demethylase activity (H3-K9 specific)(GO:0032454) |
0.1 | 0.9 | GO:0050700 | CARD domain binding(GO:0050700) |
0.1 | 0.3 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
0.1 | 0.9 | GO:0050811 | GABA receptor binding(GO:0050811) |
0.1 | 1.3 | GO:0005416 | cation:amino acid symporter activity(GO:0005416) |
0.1 | 0.5 | GO:0010340 | carboxyl-O-methyltransferase activity(GO:0010340) protein carboxyl O-methyltransferase activity(GO:0051998) |
0.1 | 0.4 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
0.1 | 0.3 | GO:0004607 | phosphatidylcholine-sterol O-acyltransferase activity(GO:0004607) |
0.1 | 0.4 | GO:0004774 | succinate-CoA ligase activity(GO:0004774) |
0.1 | 0.2 | GO:0016944 | obsolete RNA polymerase II transcription elongation factor activity(GO:0016944) |
0.1 | 0.5 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.1 | 0.3 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
0.1 | 0.4 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.1 | 0.3 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.1 | 0.2 | GO:0004527 | exonuclease activity(GO:0004527) |
0.1 | 0.3 | GO:0035004 | phosphatidylinositol 3-kinase activity(GO:0035004) |
0.1 | 0.2 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
0.1 | 0.4 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
0.1 | 0.3 | GO:0001591 | dopamine neurotransmitter receptor activity, coupled via Gi/Go(GO:0001591) |
0.1 | 1.0 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
0.1 | 0.3 | GO:0033300 | dehydroascorbic acid transporter activity(GO:0033300) |
0.1 | 0.3 | GO:0003945 | N-acetyllactosamine synthase activity(GO:0003945) |
0.1 | 0.4 | GO:0015379 | potassium:chloride symporter activity(GO:0015379) |
0.1 | 0.1 | GO:0051192 | ACP phosphopantetheine attachment site binding involved in fatty acid biosynthetic process(GO:0000036) ACP phosphopantetheine attachment site binding(GO:0044620) prosthetic group binding(GO:0051192) |
0.1 | 0.5 | GO:0031996 | thioesterase binding(GO:0031996) |
0.1 | 0.3 | GO:0043237 | laminin-1 binding(GO:0043237) |
0.1 | 0.4 | GO:0034713 | type I transforming growth factor beta receptor binding(GO:0034713) |
0.1 | 1.5 | GO:0043621 | protein self-association(GO:0043621) |
0.1 | 0.5 | GO:0070403 | NAD+ binding(GO:0070403) |
0.1 | 0.3 | GO:0043141 | ATP-dependent 5'-3' DNA helicase activity(GO:0043141) |
0.1 | 1.2 | GO:0048487 | beta-tubulin binding(GO:0048487) |
0.1 | 0.5 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.1 | 0.3 | GO:0030911 | TPR domain binding(GO:0030911) |
0.1 | 0.5 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
0.1 | 0.7 | GO:0070410 | co-SMAD binding(GO:0070410) |
0.1 | 0.2 | GO:0042166 | acetylcholine binding(GO:0042166) |
0.1 | 0.2 | GO:0034236 | protein kinase A catalytic subunit binding(GO:0034236) |
0.1 | 0.7 | GO:0001671 | ATPase activator activity(GO:0001671) |
0.1 | 0.3 | GO:0004875 | complement receptor activity(GO:0004875) |
0.1 | 0.4 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
0.1 | 1.2 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
0.1 | 0.4 | GO:0004046 | aminoacylase activity(GO:0004046) |
0.1 | 0.3 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
0.1 | 0.3 | GO:0047238 | glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity(GO:0047238) |
0.1 | 0.1 | GO:0090079 | translation regulator activity, nucleic acid binding(GO:0090079) |
0.1 | 0.1 | GO:0035514 | DNA demethylase activity(GO:0035514) DNA-N1-methyladenine dioxygenase activity(GO:0043734) |
0.1 | 0.4 | GO:0008296 | 3'-5'-exodeoxyribonuclease activity(GO:0008296) |
0.1 | 0.7 | GO:0008536 | Ran GTPase binding(GO:0008536) |
0.1 | 0.5 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
0.1 | 4.4 | GO:0008301 | DNA binding, bending(GO:0008301) |
0.1 | 0.3 | GO:0017069 | snRNA binding(GO:0017069) |
0.1 | 0.6 | GO:0031701 | angiotensin receptor binding(GO:0031701) |
0.1 | 0.3 | GO:0005114 | type II transforming growth factor beta receptor binding(GO:0005114) |
0.1 | 0.3 | GO:0003964 | telomerase activity(GO:0003720) RNA-directed DNA polymerase activity(GO:0003964) |
0.1 | 0.2 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
0.1 | 0.3 | GO:0048156 | tau protein binding(GO:0048156) |
0.1 | 0.9 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
0.1 | 1.1 | GO:0043499 | obsolete eukaryotic cell surface binding(GO:0043499) |
0.1 | 0.2 | GO:0050253 | retinyl-palmitate esterase activity(GO:0050253) |
0.1 | 0.1 | GO:0015193 | L-proline transmembrane transporter activity(GO:0015193) |
0.1 | 1.2 | GO:0004889 | acetylcholine-activated cation-selective channel activity(GO:0004889) |
0.1 | 0.2 | GO:0022897 | peptide:proton symporter activity(GO:0015333) proton-dependent peptide secondary active transmembrane transporter activity(GO:0022897) |
0.1 | 0.5 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
0.1 | 0.4 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
0.1 | 0.6 | GO:0016273 | arginine N-methyltransferase activity(GO:0016273) protein-arginine N-methyltransferase activity(GO:0016274) |
0.1 | 1.1 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.1 | 4.6 | GO:0004197 | cysteine-type endopeptidase activity(GO:0004197) |
0.1 | 0.3 | GO:0008607 | phosphorylase kinase regulator activity(GO:0008607) |
0.1 | 0.3 | GO:0003724 | RNA helicase activity(GO:0003724) |
0.1 | 0.4 | GO:0001727 | lipid kinase activity(GO:0001727) |
0.1 | 0.2 | GO:0008409 | 5'-3' exonuclease activity(GO:0008409) |
0.1 | 0.2 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
0.1 | 0.2 | GO:0004802 | transketolase activity(GO:0004802) |
0.1 | 2.1 | GO:0003725 | double-stranded RNA binding(GO:0003725) |
0.1 | 0.4 | GO:0030544 | Hsp70 protein binding(GO:0030544) |
0.1 | 1.4 | GO:0008601 | protein phosphatase type 2A regulator activity(GO:0008601) |
0.1 | 0.6 | GO:0043425 | bHLH transcription factor binding(GO:0043425) |
0.1 | 0.7 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
0.1 | 0.6 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
0.1 | 0.3 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
0.1 | 0.1 | GO:0016776 | phosphotransferase activity, phosphate group as acceptor(GO:0016776) |
0.1 | 0.4 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.1 | 0.3 | GO:0004127 | cytidylate kinase activity(GO:0004127) |
0.1 | 0.3 | GO:0016997 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) |
0.1 | 0.3 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
0.1 | 0.3 | GO:0000739 | obsolete DNA strand annealing activity(GO:0000739) |
0.1 | 0.2 | GO:0003909 | DNA ligase activity(GO:0003909) DNA ligase (ATP) activity(GO:0003910) |
0.1 | 0.2 | GO:0061731 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
0.1 | 0.2 | GO:0000247 | C-8 sterol isomerase activity(GO:0000247) |
0.1 | 0.1 | GO:0000175 | 3'-5'-exoribonuclease activity(GO:0000175) |
0.1 | 0.3 | GO:0042288 | MHC class I protein binding(GO:0042288) |
0.1 | 0.3 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
0.1 | 0.4 | GO:0051018 | protein kinase A binding(GO:0051018) |
0.1 | 0.2 | GO:0004966 | galanin receptor activity(GO:0004966) |
0.1 | 1.9 | GO:0003823 | antigen binding(GO:0003823) |
0.1 | 0.3 | GO:0016565 | obsolete general transcriptional repressor activity(GO:0016565) |
0.1 | 0.7 | GO:0033613 | activating transcription factor binding(GO:0033613) |
0.1 | 0.1 | GO:0070492 | oligosaccharide binding(GO:0070492) |
0.1 | 0.4 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
0.1 | 0.6 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.1 | 0.6 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
0.1 | 0.4 | GO:0042834 | peptidoglycan binding(GO:0042834) |
0.1 | 0.9 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.1 | 0.4 | GO:0003988 | acetyl-CoA C-acyltransferase activity(GO:0003988) |
0.1 | 0.3 | GO:0031013 | troponin I binding(GO:0031013) |
0.1 | 0.2 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.1 | 0.1 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
0.1 | 1.1 | GO:0051219 | phosphoprotein binding(GO:0051219) |
0.1 | 0.8 | GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity(GO:0008353) |
0.1 | 0.2 | GO:0032552 | deoxyribonucleotide binding(GO:0032552) |
0.1 | 0.2 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
0.1 | 0.2 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
0.1 | 1.0 | GO:0019198 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
0.1 | 0.2 | GO:0050698 | proteoglycan sulfotransferase activity(GO:0050698) |
0.1 | 0.1 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
0.1 | 0.2 | GO:0070735 | protein-glycine ligase activity(GO:0070735) |
0.1 | 0.2 | GO:0098847 | single-stranded telomeric DNA binding(GO:0043047) sequence-specific single stranded DNA binding(GO:0098847) |
0.1 | 0.2 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
0.1 | 1.5 | GO:0016831 | carboxy-lyase activity(GO:0016831) |
0.1 | 0.4 | GO:0004028 | 3-chloroallyl aldehyde dehydrogenase activity(GO:0004028) |
0.1 | 0.2 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
0.1 | 0.4 | GO:0070412 | R-SMAD binding(GO:0070412) |
0.1 | 0.1 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
0.1 | 2.2 | GO:0003697 | single-stranded DNA binding(GO:0003697) |
0.1 | 0.1 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
0.1 | 0.3 | GO:0004904 | interferon receptor activity(GO:0004904) |
0.1 | 0.4 | GO:0004568 | chitinase activity(GO:0004568) |
0.1 | 0.2 | GO:0016721 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
0.1 | 0.8 | GO:0019534 | toxin transporter activity(GO:0019534) |
0.1 | 0.2 | GO:0051733 | ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity(GO:0046404) polydeoxyribonucleotide kinase activity(GO:0051733) ATP-dependent polynucleotide kinase activity(GO:0051734) |
0.1 | 0.3 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
0.1 | 0.5 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
0.1 | 0.7 | GO:0005528 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.1 | 1.0 | GO:0050699 | WW domain binding(GO:0050699) |
0.1 | 0.2 | GO:0004946 | bombesin receptor activity(GO:0004946) |
0.1 | 1.2 | GO:0004177 | aminopeptidase activity(GO:0004177) |
0.1 | 1.3 | GO:0019843 | rRNA binding(GO:0019843) |
0.1 | 0.2 | GO:0031177 | phosphopantetheine binding(GO:0031177) |
0.1 | 0.1 | GO:0052866 | phosphatidylinositol phosphate phosphatase activity(GO:0052866) |
0.1 | 0.7 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
0.1 | 0.6 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
0.1 | 0.2 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
0.1 | 0.2 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.1 | 0.2 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.1 | 0.1 | GO:0016896 | exoribonuclease activity, producing 5'-phosphomonoesters(GO:0016896) |
0.1 | 0.2 | GO:0045569 | TRAIL binding(GO:0045569) |
0.1 | 0.4 | GO:0005522 | profilin binding(GO:0005522) |
0.1 | 3.2 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.1 | 0.1 | GO:0004428 | obsolete inositol or phosphatidylinositol kinase activity(GO:0004428) |
0.1 | 0.1 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
0.1 | 0.2 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
0.1 | 0.3 | GO:0016423 | tRNA (guanine) methyltransferase activity(GO:0016423) |
0.1 | 1.0 | GO:0003755 | peptidyl-prolyl cis-trans isomerase activity(GO:0003755) |
0.1 | 0.1 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
0.1 | 0.8 | GO:0043022 | ribosome binding(GO:0043022) |
0.1 | 0.3 | GO:0003997 | acyl-CoA oxidase activity(GO:0003997) |
0.1 | 0.2 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
0.1 | 0.3 | GO:0003678 | DNA helicase activity(GO:0003678) |
0.0 | 0.4 | GO:0017025 | TBP-class protein binding(GO:0017025) |
0.0 | 0.9 | GO:0004693 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) cyclin-dependent protein kinase activity(GO:0097472) |
0.0 | 0.2 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
0.0 | 3.9 | GO:0017124 | SH3 domain binding(GO:0017124) |
0.0 | 0.4 | GO:0004983 | neuropeptide Y receptor activity(GO:0004983) |
0.0 | 0.2 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
0.0 | 0.1 | GO:0004803 | transposase activity(GO:0004803) |
0.0 | 0.6 | GO:0010181 | FMN binding(GO:0010181) |
0.0 | 0.6 | GO:0016888 | endodeoxyribonuclease activity, producing 5'-phosphomonoesters(GO:0016888) |
0.0 | 2.2 | GO:0042393 | histone binding(GO:0042393) |
0.0 | 0.1 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
0.0 | 0.1 | GO:0070996 | type 1 melanocortin receptor binding(GO:0070996) |
0.0 | 0.1 | GO:0004952 | dopamine neurotransmitter receptor activity(GO:0004952) |
0.0 | 0.6 | GO:0005031 | tumor necrosis factor-activated receptor activity(GO:0005031) |
0.0 | 0.2 | GO:0008159 | obsolete positive transcription elongation factor activity(GO:0008159) |
0.0 | 0.7 | GO:0009881 | photoreceptor activity(GO:0009881) |
0.0 | 0.4 | GO:0048531 | beta-1,3-galactosyltransferase activity(GO:0048531) |
0.0 | 0.9 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.0 | 0.0 | GO:0009008 | DNA-methyltransferase activity(GO:0009008) |
0.0 | 0.1 | GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity(GO:0004591) |
0.0 | 0.2 | GO:0015215 | nucleotide transmembrane transporter activity(GO:0015215) |
0.0 | 1.9 | GO:0003707 | steroid hormone receptor activity(GO:0003707) |
0.0 | 0.4 | GO:0031490 | chromatin DNA binding(GO:0031490) |
0.0 | 0.2 | GO:0034979 | NAD-dependent protein deacetylase activity(GO:0034979) |
0.0 | 0.3 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.0 | 0.8 | GO:0022829 | wide pore channel activity(GO:0022829) |
0.0 | 0.4 | GO:0004385 | guanylate kinase activity(GO:0004385) |
0.0 | 0.5 | GO:0008556 | potassium-transporting ATPase activity(GO:0008556) |
0.0 | 1.0 | GO:0019829 | cation-transporting ATPase activity(GO:0019829) |
0.0 | 0.4 | GO:0071617 | 1-acylglycerol-3-phosphate O-acyltransferase activity(GO:0003841) lysophosphatidic acid acyltransferase activity(GO:0042171) lysophospholipid acyltransferase activity(GO:0071617) |
0.0 | 0.0 | GO:0030172 | troponin C binding(GO:0030172) |
0.0 | 0.1 | GO:0017070 | U6 snRNA binding(GO:0017070) |
0.0 | 0.1 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
0.0 | 4.5 | GO:0003702 | obsolete RNA polymerase II transcription factor activity(GO:0003702) |
0.0 | 0.1 | GO:0004536 | deoxyribonuclease activity(GO:0004536) |
0.0 | 0.4 | GO:0003709 | obsolete RNA polymerase III transcription factor activity(GO:0003709) |
0.0 | 0.1 | GO:0004828 | serine-tRNA ligase activity(GO:0004828) |
0.0 | 0.0 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
0.0 | 0.1 | GO:0015307 | drug:proton antiporter activity(GO:0015307) |
0.0 | 0.1 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
0.0 | 0.1 | GO:0042800 | histone methyltransferase activity (H3-K4 specific)(GO:0042800) |
0.0 | 0.2 | GO:0070491 | repressing transcription factor binding(GO:0070491) |
0.0 | 0.2 | GO:0030274 | LIM domain binding(GO:0030274) |
0.0 | 0.5 | GO:0005328 | neurotransmitter:sodium symporter activity(GO:0005328) |
0.0 | 0.1 | GO:1990939 | ATP-dependent microtubule motor activity, plus-end-directed(GO:0008574) ATP-dependent microtubule motor activity(GO:1990939) |
0.0 | 0.2 | GO:0017110 | nucleoside-diphosphatase activity(GO:0017110) |
0.0 | 0.2 | GO:0046870 | cadmium ion binding(GO:0046870) |
0.0 | 0.3 | GO:0015166 | polyol transmembrane transporter activity(GO:0015166) |
0.0 | 0.1 | GO:0015211 | purine nucleoside transmembrane transporter activity(GO:0015211) |
0.0 | 0.5 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
0.0 | 0.2 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
0.0 | 0.2 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
0.0 | 0.2 | GO:0008312 | 7S RNA binding(GO:0008312) |
0.0 | 0.2 | GO:0008242 | omega peptidase activity(GO:0008242) |
0.0 | 0.3 | GO:0051721 | protein phosphatase 2A binding(GO:0051721) |
0.0 | 0.5 | GO:0005344 | oxygen transporter activity(GO:0005344) |
0.0 | 0.2 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
0.0 | 0.0 | GO:0051425 | PTB domain binding(GO:0051425) |
0.0 | 0.2 | GO:0003747 | translation release factor activity(GO:0003747) translation termination factor activity(GO:0008079) |
0.0 | 0.3 | GO:0008171 | O-methyltransferase activity(GO:0008171) |
0.0 | 1.6 | GO:0008094 | DNA-dependent ATPase activity(GO:0008094) |
0.0 | 0.3 | GO:0046625 | sphingolipid binding(GO:0046625) |
0.0 | 0.2 | GO:0050780 | dopamine receptor binding(GO:0050780) |
0.0 | 0.1 | GO:0004938 | alpha2-adrenergic receptor activity(GO:0004938) |
0.0 | 0.6 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
0.0 | 0.2 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.0 | 0.3 | GO:0003906 | DNA-(apurinic or apyrimidinic site) lyase activity(GO:0003906) |
0.0 | 0.4 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
0.0 | 0.0 | GO:1901677 | organophosphate ester transmembrane transporter activity(GO:0015605) phosphate transmembrane transporter activity(GO:1901677) |
0.0 | 0.0 | GO:0001085 | RNA polymerase II transcription factor binding(GO:0001085) |
0.0 | 0.4 | GO:0005537 | mannose binding(GO:0005537) |
0.0 | 0.1 | GO:0004167 | dopachrome isomerase activity(GO:0004167) |
0.0 | 0.8 | GO:0016676 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors(GO:0016675) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.0 | 0.3 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
0.0 | 0.1 | GO:0070095 | fructose-6-phosphate binding(GO:0070095) |
0.0 | 0.6 | GO:0003746 | translation elongation factor activity(GO:0003746) |
0.0 | 0.1 | GO:0015038 | glutathione disulfide oxidoreductase activity(GO:0015038) |
0.0 | 1.2 | GO:0050136 | NADH dehydrogenase activity(GO:0003954) NADH dehydrogenase (ubiquinone) activity(GO:0008137) NADH dehydrogenase (quinone) activity(GO:0050136) |
0.0 | 0.4 | GO:0032393 | MHC class I receptor activity(GO:0032393) |
0.0 | 0.1 | GO:0019870 | potassium channel inhibitor activity(GO:0019870) |
0.0 | 0.0 | GO:0008545 | JUN kinase kinase activity(GO:0008545) |
0.0 | 0.6 | GO:0004843 | thiol-dependent ubiquitin-specific protease activity(GO:0004843) thiol-dependent ubiquitinyl hydrolase activity(GO:0036459) ubiquitinyl hydrolase activity(GO:0101005) |
0.0 | 0.1 | GO:0016312 | inositol bisphosphate phosphatase activity(GO:0016312) |
0.0 | 0.4 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
0.0 | 0.3 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.0 | 0.1 | GO:0031404 | chloride ion binding(GO:0031404) |
0.0 | 0.1 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.0 | 0.7 | GO:0042625 | ATPase coupled ion transmembrane transporter activity(GO:0042625) |
0.0 | 0.3 | GO:0003924 | GTPase activity(GO:0003924) |
0.0 | 0.8 | GO:0070035 | ATP-dependent helicase activity(GO:0008026) purine NTP-dependent helicase activity(GO:0070035) |
0.0 | 0.0 | GO:0015187 | glycine transmembrane transporter activity(GO:0015187) |
0.0 | 0.1 | GO:0008649 | rRNA methyltransferase activity(GO:0008649) |
0.0 | 0.3 | GO:0016251 | obsolete general RNA polymerase II transcription factor activity(GO:0016251) |
0.0 | 0.1 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
0.0 | 0.1 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
0.0 | 0.1 | GO:0003711 | obsolete transcription elongation regulator activity(GO:0003711) |
0.0 | 0.1 | GO:0048018 | receptor agonist activity(GO:0048018) |
0.0 | 0.1 | GO:0008967 | phosphoglycolate phosphatase activity(GO:0008967) |
0.0 | 0.1 | GO:0004301 | epoxide hydrolase activity(GO:0004301) |
0.0 | 0.2 | GO:0008175 | tRNA methyltransferase activity(GO:0008175) |
0.0 | 0.7 | GO:0019903 | protein phosphatase binding(GO:0019903) |
0.0 | 0.2 | GO:0005111 | type 2 fibroblast growth factor receptor binding(GO:0005111) |
0.0 | 0.1 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
0.0 | 0.1 | GO:0070628 | proteasome binding(GO:0070628) |
0.0 | 0.1 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.0 | 0.2 | GO:0004931 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
0.0 | 0.1 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
0.0 | 16.6 | GO:0003723 | RNA binding(GO:0003723) |
0.0 | 0.1 | GO:0030548 | acetylcholine receptor regulator activity(GO:0030548) neurotransmitter receptor regulator activity(GO:0099602) |
0.0 | 0.1 | GO:0016634 | oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor(GO:0016634) |
0.0 | 0.5 | GO:0019205 | nucleobase-containing compound kinase activity(GO:0019205) |
0.0 | 0.1 | GO:0008559 | xenobiotic-transporting ATPase activity(GO:0008559) xenobiotic transporter activity(GO:0042910) |
0.0 | 0.0 | GO:0004813 | alanine-tRNA ligase activity(GO:0004813) |
0.0 | 1.0 | GO:0003682 | chromatin binding(GO:0003682) |
0.0 | 0.0 | GO:0003896 | DNA primase activity(GO:0003896) |
0.0 | 0.1 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.0 | 0.3 | GO:0030553 | cGMP binding(GO:0030553) |
0.0 | 0.2 | GO:0030276 | clathrin binding(GO:0030276) |
0.0 | 0.1 | GO:0043021 | ribonucleoprotein complex binding(GO:0043021) |
0.0 | 0.6 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.0 | 0.1 | GO:0001848 | complement binding(GO:0001848) |
0.0 | 0.2 | GO:0015175 | neutral amino acid transmembrane transporter activity(GO:0015175) |
0.0 | 0.1 | GO:0030881 | beta-2-microglobulin binding(GO:0030881) |
0.0 | 0.1 | GO:0004955 | prostaglandin receptor activity(GO:0004955) |
0.0 | 0.7 | GO:0001948 | glycoprotein binding(GO:0001948) |
0.0 | 0.0 | GO:0001758 | retinal dehydrogenase activity(GO:0001758) |
0.0 | 0.3 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.0 | 0.1 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
0.0 | 0.2 | GO:0035251 | UDP-glucosyltransferase activity(GO:0035251) |
0.0 | 0.1 | GO:0016530 | metallochaperone activity(GO:0016530) |
0.0 | 0.2 | GO:0008158 | hedgehog receptor activity(GO:0008158) |
0.0 | 0.1 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.0 | 0.3 | GO:0030145 | manganese ion binding(GO:0030145) |
0.0 | 0.3 | GO:1905030 | voltage-gated sodium channel activity(GO:0005248) voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1905030) |
0.0 | 0.1 | GO:0016748 | succinyltransferase activity(GO:0016748) |
0.0 | 0.1 | GO:0042165 | neurotransmitter binding(GO:0042165) |
0.0 | 0.4 | GO:0008484 | sulfuric ester hydrolase activity(GO:0008484) |
0.0 | 0.0 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
0.0 | 0.2 | GO:0034062 | DNA-directed RNA polymerase activity(GO:0003899) RNA polymerase activity(GO:0034062) |
0.0 | 0.2 | GO:0004659 | prenyltransferase activity(GO:0004659) |
0.0 | 0.1 | GO:0005160 | transforming growth factor beta receptor binding(GO:0005160) |
0.0 | 0.1 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
0.0 | 0.1 | GO:0005326 | neurotransmitter transporter activity(GO:0005326) |
0.0 | 0.1 | GO:0046923 | ER retention sequence binding(GO:0046923) |
0.0 | 0.1 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
0.0 | 0.1 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
0.0 | 0.1 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
0.0 | 0.0 | GO:0070215 | obsolete MDM2 binding(GO:0070215) |
0.0 | 0.1 | GO:0015643 | toxic substance binding(GO:0015643) |
0.0 | 0.1 | GO:0004985 | opioid receptor activity(GO:0004985) |
0.0 | 0.1 | GO:0036137 | kynurenine-oxoglutarate transaminase activity(GO:0016212) kynurenine aminotransferase activity(GO:0036137) |
0.0 | 0.1 | GO:0003705 | transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0003705) |
0.0 | 0.0 | GO:0016362 | activin receptor activity, type II(GO:0016362) |
0.0 | 0.1 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
0.0 | 0.1 | GO:0019213 | deacetylase activity(GO:0019213) |
0.0 | 0.3 | GO:0051117 | ATPase binding(GO:0051117) |
0.0 | 0.1 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.0 | 0.1 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
0.0 | 0.4 | GO:0051087 | chaperone binding(GO:0051087) |
0.0 | 4.3 | GO:0003676 | nucleic acid binding(GO:0003676) |
0.0 | 0.5 | GO:0016875 | aminoacyl-tRNA ligase activity(GO:0004812) ligase activity, forming carbon-oxygen bonds(GO:0016875) ligase activity, forming aminoacyl-tRNA and related compounds(GO:0016876) |
0.0 | 33.1 | GO:0003677 | DNA binding(GO:0003677) |
0.0 | 0.3 | GO:0016646 | oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor(GO:0016646) |
0.0 | 0.1 | GO:0008401 | retinoic acid 4-hydroxylase activity(GO:0008401) |
0.0 | 0.4 | GO:0008376 | acetylgalactosaminyltransferase activity(GO:0008376) |
0.0 | 0.1 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
0.0 | 0.1 | GO:0016799 | hydrolase activity, hydrolyzing N-glycosyl compounds(GO:0016799) |
0.0 | 0.6 | GO:0047485 | protein N-terminus binding(GO:0047485) |
0.0 | 0.1 | GO:0004873 | asialoglycoprotein receptor activity(GO:0004873) |
0.0 | 5.7 | GO:0019001 | guanyl nucleotide binding(GO:0019001) guanyl ribonucleotide binding(GO:0032561) |
0.0 | 0.1 | GO:0008486 | diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) |
0.0 | 3.8 | GO:0030695 | GTPase regulator activity(GO:0030695) |
0.0 | 0.1 | GO:0005436 | sodium:phosphate symporter activity(GO:0005436) |
0.0 | 0.1 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.0 | 0.0 | GO:0004972 | NMDA glutamate receptor activity(GO:0004972) |
0.0 | 0.2 | GO:0051184 | cofactor transporter activity(GO:0051184) |
0.0 | 0.1 | GO:0016742 | hydroxymethyl-, formyl- and related transferase activity(GO:0016742) |
0.0 | 0.3 | GO:0048306 | calcium-dependent protein binding(GO:0048306) |
0.0 | 0.1 | GO:0004549 | tRNA-specific ribonuclease activity(GO:0004549) |
0.0 | 0.1 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
0.0 | 0.1 | GO:0098599 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.0 | 0.1 | GO:0015355 | secondary active monocarboxylate transmembrane transporter activity(GO:0015355) |
0.0 | 0.3 | GO:0004890 | GABA-A receptor activity(GO:0004890) |
0.0 | 0.2 | GO:0016884 | carbon-nitrogen ligase activity, with glutamine as amido-N-donor(GO:0016884) |
0.0 | 0.1 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
0.0 | 0.1 | GO:0004064 | arylesterase activity(GO:0004064) |
0.0 | 0.0 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
0.0 | 0.1 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
0.0 | 0.1 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.0 | 0.1 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.0 | 0.1 | GO:0032395 | MHC class II receptor activity(GO:0032395) |
0.0 | 0.0 | GO:0017060 | 3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase activity(GO:0017060) |
0.0 | 0.0 | GO:0019956 | chemokine binding(GO:0019956) |
0.0 | 0.0 | GO:0018685 | alkane 1-monooxygenase activity(GO:0018685) |
0.0 | 0.3 | GO:0004683 | calmodulin-dependent protein kinase activity(GO:0004683) |
0.0 | 0.0 | GO:0030023 | extracellular matrix constituent conferring elasticity(GO:0030023) structural molecule activity conferring elasticity(GO:0097493) |
0.0 | 0.0 | GO:0044390 | ubiquitin conjugating enzyme binding(GO:0031624) ubiquitin-like protein conjugating enzyme binding(GO:0044390) |
0.0 | 0.2 | GO:0004518 | nuclease activity(GO:0004518) |
0.0 | 0.0 | GO:0015464 | acetylcholine receptor activity(GO:0015464) |
0.0 | 2.3 | GO:0019787 | ubiquitin-like protein transferase activity(GO:0019787) |
0.0 | 1.0 | GO:0051082 | unfolded protein binding(GO:0051082) |
0.0 | 0.0 | GO:0004953 | icosanoid receptor activity(GO:0004953) |
0.0 | 0.3 | GO:0004869 | cysteine-type endopeptidase inhibitor activity(GO:0004869) |
0.0 | 0.0 | GO:0070411 | I-SMAD binding(GO:0070411) |
0.0 | 0.0 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
0.0 | 0.1 | GO:0070567 | cytidylyltransferase activity(GO:0070567) |
0.0 | 0.0 | GO:0098531 | RNA polymerase II transcription factor activity, ligand-activated sequence-specific DNA binding(GO:0004879) transcription factor activity, direct ligand regulated sequence-specific DNA binding(GO:0098531) |
0.0 | 0.7 | GO:0005262 | calcium channel activity(GO:0005262) |
0.0 | 0.0 | GO:0008432 | JUN kinase binding(GO:0008432) |
0.0 | 0.0 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
0.0 | 0.1 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
0.0 | 0.1 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
0.0 | 0.7 | GO:0008565 | protein transporter activity(GO:0008565) |
0.0 | 0.2 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
0.0 | 0.0 | GO:0004090 | carbonyl reductase (NADPH) activity(GO:0004090) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.4 | 20.8 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
0.3 | 2.9 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.3 | 5.0 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
0.2 | 2.7 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.2 | 0.2 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
0.2 | 4.3 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.2 | 2.8 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.2 | 6.9 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.2 | 6.4 | PID TNF PATHWAY | TNF receptor signaling pathway |
0.2 | 3.9 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.1 | 1.4 | PID GMCSF PATHWAY | GMCSF-mediated signaling events |
0.1 | 0.1 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
0.1 | 6.0 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.1 | 5.4 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.1 | 0.8 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.1 | 0.3 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.1 | 0.1 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.1 | 3.0 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.1 | 1.3 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.1 | 3.0 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.1 | 1.3 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.1 | 0.2 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.1 | 0.6 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
0.1 | 2.9 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.1 | 1.3 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
0.1 | 0.5 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.1 | 0.1 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.1 | 1.6 | PID MYC PATHWAY | C-MYC pathway |
0.1 | 0.6 | PID S1P S1P1 PATHWAY | S1P1 pathway |
0.1 | 1.9 | PID BCR 5PATHWAY | BCR signaling pathway |
0.1 | 0.1 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.1 | 0.9 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.1 | 0.5 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.1 | 0.6 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.1 | 0.8 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.1 | 0.6 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.1 | 0.7 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.1 | 0.8 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.1 | 0.1 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.1 | 2.6 | PID LKB1 PATHWAY | LKB1 signaling events |
0.1 | 0.5 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
0.1 | 0.8 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.1 | 0.8 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
0.1 | 0.1 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.1 | 0.1 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.1 | 0.6 | PID ARF6 PATHWAY | Arf6 signaling events |
0.1 | 0.5 | PID IFNG PATHWAY | IFN-gamma pathway |
0.1 | 0.8 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
0.0 | 0.8 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.0 | 0.7 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
0.0 | 0.2 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
0.0 | 0.2 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.0 | 0.0 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.0 | 0.5 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.0 | 0.2 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
0.0 | 0.2 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.0 | 0.6 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.0 | 0.0 | PID HIV NEF PATHWAY | HIV-1 Nef: Negative effector of Fas and TNF-alpha |
0.0 | 0.1 | SIG PIP3 SIGNALING IN CARDIAC MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
0.0 | 0.7 | PID ALK1 PATHWAY | ALK1 signaling events |
0.0 | 0.2 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.0 | 2.1 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
0.0 | 0.2 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.0 | 0.8 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.0 | 2.0 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.0 | 1.4 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.0 | 0.3 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
0.0 | 0.1 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
0.0 | 1.2 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.0 | 0.5 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.0 | 0.1 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.0 | 0.8 | PID CDC42 PATHWAY | CDC42 signaling events |
0.0 | 0.1 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.0 | 1.0 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
0.0 | 0.4 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.0 | 0.0 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.0 | 0.4 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.0 | 0.3 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.0 | 0.4 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.0 | 0.3 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.0 | 0.5 | PID RAS PATHWAY | Regulation of Ras family activation |
0.0 | 0.1 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.0 | 0.9 | PID MTOR 4PATHWAY | mTOR signaling pathway |
0.0 | 0.8 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.0 | 0.8 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.0 | 0.7 | PID BARD1 PATHWAY | BARD1 signaling events |
0.0 | 1.0 | PID PLK1 PATHWAY | PLK1 signaling events |
0.0 | 1.0 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.0 | 0.1 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.0 | 0.3 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.0 | 0.3 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.0 | 0.4 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.0 | 0.1 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
0.0 | 0.1 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
0.0 | 0.0 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.0 | 0.5 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
0.0 | 1.0 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
0.0 | 0.2 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.0 | 0.1 | PID S1P META PATHWAY | Sphingosine 1-phosphate (S1P) pathway |
0.0 | 0.4 | PID PDGFRB PATHWAY | PDGFR-beta signaling pathway |
0.0 | 0.6 | PID P53 REGULATION PATHWAY | p53 pathway |
0.0 | 0.0 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
0.0 | 0.0 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.0 | 0.3 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.0 | 0.1 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.0 | 0.2 | PID ATR PATHWAY | ATR signaling pathway |
0.0 | 0.2 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.0 | 0.1 | PID AURORA A PATHWAY | Aurora A signaling |
0.0 | 0.0 | PID ALK2 PATHWAY | ALK2 signaling events |
0.0 | 0.1 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
0.0 | 0.0 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.0 | 0.2 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.0 | 0.1 | SIG CHEMOTAXIS | Genes related to chemotaxis |
0.0 | 0.0 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.0 | 0.2 | PID HEDGEHOG GLI PATHWAY | Hedgehog signaling events mediated by Gli proteins |
0.0 | 0.2 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.0 | 0.0 | PID REELIN PATHWAY | Reelin signaling pathway |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.6 | 1.8 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
0.5 | 5.2 | REACTOME CD28 DEPENDENT VAV1 PATHWAY | Genes involved in CD28 dependent Vav1 pathway |
0.4 | 8.6 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
0.4 | 1.5 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
0.3 | 3.8 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
0.2 | 5.3 | REACTOME TCR SIGNALING | Genes involved in TCR signaling |
0.2 | 1.8 | REACTOME ACTIVATION OF RAC | Genes involved in Activation of Rac |
0.2 | 5.0 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.2 | 0.2 | REACTOME SEMA3A PAK DEPENDENT AXON REPULSION | Genes involved in Sema3A PAK dependent Axon repulsion |
0.2 | 1.9 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.2 | 3.4 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.2 | 0.2 | REACTOME PROSTACYCLIN SIGNALLING THROUGH PROSTACYCLIN RECEPTOR | Genes involved in Prostacyclin signalling through prostacyclin receptor |
0.2 | 0.7 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
0.2 | 2.2 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.2 | 1.7 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.2 | 4.9 | REACTOME COSTIMULATION BY THE CD28 FAMILY | Genes involved in Costimulation by the CD28 family |
0.2 | 3.2 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.1 | 3.2 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
0.1 | 0.3 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
0.1 | 0.8 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
0.1 | 2.5 | REACTOME IL 3 5 AND GM CSF SIGNALING | Genes involved in Interleukin-3, 5 and GM-CSF signaling |
0.1 | 6.1 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
0.1 | 2.9 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
0.1 | 2.5 | REACTOME REGULATORY RNA PATHWAYS | Genes involved in Regulatory RNA pathways |
0.1 | 0.5 | REACTOME N GLYCAN ANTENNAE ELONGATION IN THE MEDIAL TRANS GOLGI | Genes involved in N-glycan antennae elongation in the medial/trans-Golgi |
0.1 | 1.7 | REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
0.1 | 3.4 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.1 | 4.9 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.1 | 0.5 | REACTOME REGULATION OF THE FANCONI ANEMIA PATHWAY | Genes involved in Regulation of the Fanconi anemia pathway |
0.1 | 0.3 | REACTOME ABORTIVE ELONGATION OF HIV1 TRANSCRIPT IN THE ABSENCE OF TAT | Genes involved in Abortive elongation of HIV-1 transcript in the absence of Tat |
0.1 | 4.3 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.1 | 1.1 | REACTOME GRB2 SOS PROVIDES LINKAGE TO MAPK SIGNALING FOR INTERGRINS | Genes involved in GRB2:SOS provides linkage to MAPK signaling for Intergrins |
0.1 | 1.2 | REACTOME HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Highly calcium permeable postsynaptic nicotinic acetylcholine receptors |
0.1 | 1.7 | REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS | Genes involved in Regulation of gene expression in beta cells |
0.1 | 1.0 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.1 | 1.4 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
0.1 | 0.7 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
0.1 | 0.3 | REACTOME IRAK2 MEDIATED ACTIVATION OF TAK1 COMPLEX UPON TLR7 8 OR 9 STIMULATION | Genes involved in IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation |
0.1 | 1.3 | REACTOME REGULATION OF AMPK ACTIVITY VIA LKB1 | Genes involved in Regulation of AMPK activity via LKB1 |
0.1 | 3.2 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
0.1 | 0.4 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
0.1 | 1.1 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
0.1 | 2.6 | REACTOME APOPTOTIC CLEAVAGE OF CELLULAR PROTEINS | Genes involved in Apoptotic cleavage of cellular proteins |
0.1 | 0.3 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
0.1 | 1.3 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
0.1 | 0.6 | REACTOME TRAF6 MEDIATED NFKB ACTIVATION | Genes involved in TRAF6 mediated NF-kB activation |
0.1 | 0.3 | REACTOME APOBEC3G MEDIATED RESISTANCE TO HIV1 INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
0.1 | 0.7 | REACTOME TRAFFICKING OF GLUR2 CONTAINING AMPA RECEPTORS | Genes involved in Trafficking of GluR2-containing AMPA receptors |
0.1 | 0.2 | REACTOME S PHASE | Genes involved in S Phase |
0.1 | 1.2 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
0.1 | 0.6 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
0.1 | 0.8 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
0.1 | 0.4 | REACTOME EICOSANOID LIGAND BINDING RECEPTORS | Genes involved in Eicosanoid ligand-binding receptors |
0.1 | 0.7 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
0.1 | 0.8 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
0.1 | 0.7 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.1 | 0.7 | REACTOME OPSINS | Genes involved in Opsins |
0.1 | 0.1 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.1 | 0.1 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION | Genes involved in TRAF6 mediated IRF7 activation |
0.1 | 0.8 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
0.1 | 5.3 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
0.1 | 0.5 | REACTOME RAF MAP KINASE CASCADE | Genes involved in RAF/MAP kinase cascade |
0.1 | 1.0 | REACTOME FORMATION OF INCISION COMPLEX IN GG NER | Genes involved in Formation of incision complex in GG-NER |
0.1 | 0.8 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.1 | 0.8 | REACTOME NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR NLR SIGNALING PATHWAYS | Genes involved in Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways |
0.1 | 0.7 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
0.1 | 0.4 | REACTOME ASSOCIATION OF LICENSING FACTORS WITH THE PRE REPLICATIVE COMPLEX | Genes involved in Association of licensing factors with the pre-replicative complex |
0.1 | 0.4 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.1 | 0.2 | REACTOME ARMS MEDIATED ACTIVATION | Genes involved in ARMS-mediated activation |
0.0 | 0.0 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.0 | 0.9 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
0.0 | 0.7 | REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
0.0 | 1.1 | REACTOME G ALPHA1213 SIGNALLING EVENTS | Genes involved in G alpha (12/13) signalling events |
0.0 | 0.9 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
0.0 | 0.9 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.0 | 0.7 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
0.0 | 0.2 | REACTOME DESTABILIZATION OF MRNA BY AUF1 HNRNP D0 | Genes involved in Destabilization of mRNA by AUF1 (hnRNP D0) |
0.0 | 0.1 | REACTOME ACTIVATION OF THE MRNA UPON BINDING OF THE CAP BINDING COMPLEX AND EIFS AND SUBSEQUENT BINDING TO 43S | Genes involved in Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S |
0.0 | 1.0 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
0.0 | 0.8 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
0.0 | 2.1 | REACTOME ER PHAGOSOME PATHWAY | Genes involved in ER-Phagosome pathway |
0.0 | 0.1 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.0 | 0.3 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.0 | 2.9 | REACTOME RESPIRATORY ELECTRON TRANSPORT ATP SYNTHESIS BY CHEMIOSMOTIC COUPLING AND HEAT PRODUCTION BY UNCOUPLING PROTEINS | Genes involved in Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins. |
0.0 | 0.5 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
0.0 | 0.8 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 2 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 2 Promoter |
0.0 | 0.3 | REACTOME TETRAHYDROBIOPTERIN BH4 SYNTHESIS RECYCLING SALVAGE AND REGULATION | Genes involved in Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation |
0.0 | 0.2 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.0 | 0.7 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
0.0 | 0.7 | REACTOME PYRUVATE METABOLISM | Genes involved in Pyruvate metabolism |
0.0 | 0.2 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
0.0 | 0.6 | REACTOME RNA POL II TRANSCRIPTION PRE INITIATION AND PROMOTER OPENING | Genes involved in RNA Polymerase II Transcription Pre-Initiation And Promoter Opening |
0.0 | 0.1 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
0.0 | 0.8 | REACTOME INSULIN RECEPTOR RECYCLING | Genes involved in Insulin receptor recycling |
0.0 | 0.3 | REACTOME PKB MEDIATED EVENTS | Genes involved in PKB-mediated events |
0.0 | 0.8 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
0.0 | 1.8 | REACTOME FORMATION OF THE TERNARY COMPLEX AND SUBSEQUENTLY THE 43S COMPLEX | Genes involved in Formation of the ternary complex, and subsequently, the 43S complex |
0.0 | 1.5 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
0.0 | 0.2 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
0.0 | 0.1 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.0 | 0.7 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.0 | 1.8 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
0.0 | 0.6 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.0 | 0.4 | REACTOME REPAIR SYNTHESIS FOR GAP FILLING BY DNA POL IN TC NER | Genes involved in Repair synthesis for gap-filling by DNA polymerase in TC-NER |
0.0 | 0.9 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
0.0 | 0.1 | REACTOME INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |
0.0 | 0.5 | REACTOME GLUCAGON TYPE LIGAND RECEPTORS | Genes involved in Glucagon-type ligand receptors |
0.0 | 1.2 | REACTOME DOWNSTREAM SIGNAL TRANSDUCTION | Genes involved in Downstream signal transduction |
0.0 | 4.1 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
0.0 | 0.5 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
0.0 | 0.4 | REACTOME DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING | Genes involved in Downregulation of TGF-beta receptor signaling |
0.0 | 0.1 | REACTOME MRNA CAPPING | Genes involved in mRNA Capping |
0.0 | 0.2 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
0.0 | 0.2 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.0 | 0.2 | REACTOME APC C CDC20 MEDIATED DEGRADATION OF MITOTIC PROTEINS | Genes involved in APC/C:Cdc20 mediated degradation of mitotic proteins |
0.0 | 1.1 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.0 | 0.1 | REACTOME RNA POL I TRANSCRIPTION | Genes involved in RNA Polymerase I Transcription |
0.0 | 0.5 | REACTOME SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE | Genes involved in SRP-dependent cotranslational protein targeting to membrane |
0.0 | 0.2 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 3 Promoter |
0.0 | 0.4 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
0.0 | 0.3 | REACTOME G PROTEIN ACTIVATION | Genes involved in G-protein activation |
0.0 | 0.4 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
0.0 | 0.2 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
0.0 | 0.4 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
0.0 | 0.4 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
0.0 | 1.8 | REACTOME MEIOTIC SYNAPSIS | Genes involved in Meiotic Synapsis |
0.0 | 1.4 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
0.0 | 0.3 | REACTOME CREB PHOSPHORYLATION THROUGH THE ACTIVATION OF RAS | Genes involved in CREB phosphorylation through the activation of Ras |
0.0 | 0.5 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
0.0 | 0.2 | REACTOME MRNA PROCESSING | Genes involved in mRNA Processing |
0.0 | 0.4 | REACTOME SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI | Genes involved in Synthesis of glycosylphosphatidylinositol (GPI) |
0.0 | 0.3 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.0 | 0.1 | REACTOME TRAF3 DEPENDENT IRF ACTIVATION PATHWAY | Genes involved in TRAF3-dependent IRF activation pathway |
0.0 | 0.8 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.0 | 0.2 | REACTOME REGULATION OF WATER BALANCE BY RENAL AQUAPORINS | Genes involved in Regulation of Water Balance by Renal Aquaporins |
0.0 | 0.7 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.0 | 0.8 | REACTOME HOST INTERACTIONS OF HIV FACTORS | Genes involved in Host Interactions of HIV factors |
0.0 | 0.1 | REACTOME FORMATION OF TRANSCRIPTION COUPLED NER TC NER REPAIR COMPLEX | Genes involved in Formation of transcription-coupled NER (TC-NER) repair complex |
0.0 | 0.4 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
0.0 | 0.3 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.0 | 0.8 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.0 | 0.2 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
0.0 | 0.0 | REACTOME RIG I MDA5 MEDIATED INDUCTION OF IFN ALPHA BETA PATHWAYS | Genes involved in RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways |
0.0 | 0.1 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.0 | 0.2 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.0 | 0.1 | REACTOME PRE NOTCH TRANSCRIPTION AND TRANSLATION | Genes involved in Pre-NOTCH Transcription and Translation |
0.0 | 0.0 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
0.0 | 0.2 | REACTOME RNA POL I TRANSCRIPTION INITIATION | Genes involved in RNA Polymerase I Transcription Initiation |
0.0 | 0.2 | REACTOME CELL DEATH SIGNALLING VIA NRAGE NRIF AND NADE | Genes involved in Cell death signalling via NRAGE, NRIF and NADE |
0.0 | 0.2 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
0.0 | 1.0 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.0 | 0.0 | REACTOME PROLONGED ERK ACTIVATION EVENTS | Genes involved in Prolonged ERK activation events |
0.0 | 0.6 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.0 | 0.5 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
0.0 | 0.2 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
0.0 | 0.6 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.0 | 0.6 | REACTOME ASPARAGINE N LINKED GLYCOSYLATION | Genes involved in Asparagine N-linked glycosylation |
0.0 | 0.2 | REACTOME EXTENSION OF TELOMERES | Genes involved in Extension of Telomeres |
0.0 | 0.0 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
0.0 | 4.2 | REACTOME GENERIC TRANSCRIPTION PATHWAY | Genes involved in Generic Transcription Pathway |
0.0 | 0.2 | REACTOME ACTIVATION OF GENES BY ATF4 | Genes involved in Activation of Genes by ATF4 |
0.0 | 0.2 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
0.0 | 0.2 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
0.0 | 0.2 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
0.0 | 0.0 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.0 | 0.2 | REACTOME FGFR4 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR4 ligand binding and activation |
0.0 | 0.2 | REACTOME SIGNALING BY EGFR IN CANCER | Genes involved in Signaling by EGFR in Cancer |
0.0 | 0.2 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
0.0 | 0.9 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.0 | 1.1 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.0 | 0.0 | REACTOME P53 DEPENDENT G1 DNA DAMAGE RESPONSE | Genes involved in p53-Dependent G1 DNA Damage Response |
0.0 | 0.0 | REACTOME PRESYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Presynaptic nicotinic acetylcholine receptors |
0.0 | 0.5 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.0 | 0.1 | REACTOME FORMATION OF TUBULIN FOLDING INTERMEDIATES BY CCT TRIC | Genes involved in Formation of tubulin folding intermediates by CCT/TriC |
0.0 | 0.1 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.0 | 0.1 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
0.0 | 0.0 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.0 | 0.0 | REACTOME CYCLIN E ASSOCIATED EVENTS DURING G1 S TRANSITION | Genes involved in Cyclin E associated events during G1/S transition |
0.0 | 0.3 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
0.0 | 0.0 | REACTOME UNFOLDED PROTEIN RESPONSE | Genes involved in Unfolded Protein Response |
0.0 | 0.3 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.0 | 0.1 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
0.0 | 0.1 | REACTOME TRANSLATION | Genes involved in Translation |
0.0 | 0.1 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |